<?xml version='1.0' encoding='UTF-8'?>
<uniprot xmlns="http://uniprot.org/uniprot" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://uniprot.org/uniprot http://www.uniprot.org/support/docs/uniprot.xsd">
<entry dataset="Swiss-Prot" created="1996-10-01" modified="2017-05-10" version="197">
<accession>P53350</accession>
<accession>Q15153</accession>
<accession>Q99746</accession>
<name>PLK1_HUMAN</name>
<protein>
<recommendedName>
<fullName>Serine/threonine-protein kinase PLK1</fullName>
<ecNumber>2.7.11.21</ecNumber>
</recommendedName>
<alternativeName>
<fullName>Polo-like kinase 1</fullName>
<shortName>PLK-1</shortName>
</alternativeName>
<alternativeName>
<fullName>Serine/threonine-protein kinase 13</fullName>
<shortName>STPK13</shortName>
</alternativeName>
</protein>
<gene>
<name type="primary">PLK1</name>
<name type="synonym">PLK</name>
</gene>
<organism>
<name type="scientific">Homo sapiens</name>
<name type="common">Human</name>
<dbReference type="NCBI Taxonomy" id="9606"/>
<lineage>
<taxon>Eukaryota</taxon>
<taxon>Metazoa</taxon>
<taxon>Chordata</taxon>
<taxon>Craniata</taxon>
<taxon>Vertebrata</taxon>
<taxon>Euteleostomi</taxon>
<taxon>Mammalia</taxon>
<taxon>Eutheria</taxon>
<taxon>Euarchontoglires</taxon>
<taxon>Primates</taxon>
<taxon>Haplorrhini</taxon>
<taxon>Catarrhini</taxon>
<taxon>Hominidae</taxon>
<taxon>Homo</taxon>
</lineage>
</organism>
<reference key="1">
<citation type="journal article" date="1994" name="Cell Growth Differ." volume="5" first="249" last="257">
<title>Cloning and characterization of human and murine homologues of the Drosophila polo serine-threonine kinase.</title>
<authorList>
<person name="Hamanaka R."/>
<person name="Maloid S."/>
<person name="Smith M.R."/>
<person name="O'Connell C.D."/>
<person name="Longo D.L."/>
<person name="Ferris D.K."/>
</authorList>
<dbReference type="PubMed" id="8018557"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA]</scope>
<source>
<tissue>Placenta</tissue>
</source>
</reference>
<reference key="2">
<citation type="journal article" date="1993" name="Mol. Cell. Biol." volume="13" first="7793" last="7801">
<title>Cell cycle- and terminal differentiation-associated regulation of the mouse mRNA encoding a conserved mitotic protein kinase.</title>
<authorList>
<person name="Lake R.J."/>
<person name="Jelinek W.R."/>
</authorList>
<dbReference type="PubMed" id="7902533"/>
<dbReference type="DOI" id="10.1128/MCB.13.12.7793"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA]</scope>
</reference>
<reference key="3">
<citation type="journal article" date="1994" name="J. Cell Sci." volume="107" first="1509" last="1517">
<title>Cell cycle analysis and chromosomal localization of human Plk1, a putative homologue of the mitotic kinases Drosophila polo and Saccharomyces cerevisiae Cdc5.</title>
<authorList>
<person name="Golsteyn R.M."/>
<person name="Schultz S.J."/>
<person name="Bartek J."/>
<person name="Ziemiecki A."/>
<person name="Ried T."/>
<person name="Nigg E.A."/>
</authorList>
<dbReference type="PubMed" id="7962193"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA]</scope>
</reference>
<reference key="4">
<citation type="journal article" date="1994" name="Proc. Natl. Acad. Sci. U.S.A." volume="91" first="1736" last="1740">
<title>Induction and down-regulation of PLK, a human serine/threonine kinase expressed in proliferating cells and tumors.</title>
<authorList>
<person name="Holtrich U."/>
<person name="Wolf G."/>
<person name="Braeuninger A."/>
<person name="Karn T."/>
<person name="Boehme B."/>
<person name="Ruebsamen-Waigmann H."/>
<person name="Strebhardt K."/>
</authorList>
<dbReference type="PubMed" id="8127874"/>
<dbReference type="DOI" id="10.1073/pnas.91.5.1736"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA]</scope>
<source>
<tissue>Lung</tissue>
</source>
</reference>
<reference key="5">
<citation type="journal article" date="2004" name="Genome Res." volume="14" first="2121" last="2127">
<title>The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC).</title>
<authorList>
<consortium name="The MGC Project Team"/>
</authorList>
<dbReference type="PubMed" id="15489334"/>
<dbReference type="DOI" id="10.1101/gr.2596504"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA]</scope>
<source>
<tissue>Colon</tissue>
<tissue>Lung</tissue>
</source>
</reference>
<reference key="6">
<citation type="journal article" date="1995" name="Oncogene" volume="11" first="1793" last="1800">
<title>Identification and functional characterization of the human and murine polo-like kinase (Plk) promoter.</title>
<authorList>
<person name="Brauninger A."/>
<person name="Strebhardt K."/>
<person name="Rubsamen-Waigmann H."/>
</authorList>
<dbReference type="PubMed" id="7478607"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 1-136</scope>
</reference>
<reference key="7">
<citation type="journal article" date="1997" name="J. Biol. Chem." volume="272" first="9166" last="9174">
<title>Cell cycle regulation of the human polo-like kinase (PLK) promoter.</title>
<authorList>
<person name="Uchiumi T."/>
<person name="Longo D.L."/>
<person name="Ferris D.K."/>
</authorList>
<dbReference type="PubMed" id="9083047"/>
<dbReference type="DOI" id="10.1074/jbc.272.14.9166"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 1-136</scope>
</reference>
<reference key="8">
<citation type="journal article" date="1996" name="J. Cell Biol." volume="135" first="1701" last="1713">
<title>Antibody microinjection reveals an essential role for human polo-like kinase 1 (Plk1) in the functional maturation of mitotic centrosomes.</title>
<authorList>
<person name="Lane H.A."/>
<person name="Nigg E.A."/>
</authorList>
<dbReference type="PubMed" id="8991084"/>
<dbReference type="DOI" id="10.1083/jcb.135.6.1701"/>
</citation>
<scope>FUNCTION IN CENTROSOME MATURATION</scope>
<scope>SUBCELLULAR LOCATION</scope>
</reference>
<reference key="9">
<citation type="journal article" date="2000" name="Cell. Signal." volume="12" first="405" last="411">
<title>The human polo-like kinase, PLK, regulates cdc2/cyclin B through phosphorylation and activation of the cdc25C phosphatase.</title>
<authorList>
<person name="Roshak A.K."/>
<person name="Capper E.A."/>
<person name="Imburgia C."/>
<person name="Fornwald J."/>
<person name="Scott G."/>
<person name="Marshall L.A."/>
</authorList>
<dbReference type="PubMed" id="11202906"/>
<dbReference type="DOI" id="10.1016/S0898-6568(00)00080-2"/>
</citation>
<scope>FUNCTION IN PHOSPHORYLATION OF CDC25C</scope>
</reference>
<reference key="10">
<citation type="journal article" date="2002" name="J. Biol. Chem." volume="277" first="44115" last="44120">
<title>Phosphorylation of threonine 210 and the role of serine 137 in the regulation of mammalian polo-like kinase.</title>
<authorList>
<person name="Jang Y.-J."/>
<person name="Ma S."/>
<person name="Terada Y."/>
<person name="Erikson R.L."/>
</authorList>
<dbReference type="PubMed" id="12207013"/>
<dbReference type="DOI" id="10.1074/jbc.M202172200"/>
</citation>
<scope>FUNCTION</scope>
<scope>PHOSPHORYLATION AT SER-137 AND THR-210</scope>
<scope>MUTAGENESIS OF LYS-82; SER-137 AND THR-210</scope>
</reference>
<reference key="11">
<citation type="journal article" date="2002" name="Oncogene" volume="21" first="8282" last="8292">
<title>Cooperative phosphorylation including the activity of polo-like kinase 1 regulates the subcellular localization of cyclin B1.</title>
<authorList>
<person name="Yuan J."/>
<person name="Eckerdt F."/>
<person name="Bereiter-Hahn J."/>
<person name="Kurunci-Csacsko E."/>
<person name="Kaufmann M."/>
<person name="Strebhardt K."/>
</authorList>
<dbReference type="PubMed" id="12447691"/>
<dbReference type="DOI" id="10.1038/sj.onc.1206011"/>
</citation>
<scope>FUNCTION IN PHOSPHORYLATION OF CCNB1</scope>
<scope>SUBCELLULAR LOCATION</scope>
<scope>MUTAGENESIS OF LYS-82 AND THR-210</scope>
</reference>
<reference key="12">
<citation type="journal article" date="2002" name="Proteomics" volume="2" first="1516" last="1523">
<title>Identification of phosphorylation sites in the polo-like kinases Plx1 and Plk1 by a novel strategy based on element and electrospray high resolution mass spectrometry.</title>
<authorList>
<person name="Wind M."/>
<person name="Kelm O."/>
<person name="Nigg E.A."/>
<person name="Lehmann W.D."/>
</authorList>
<dbReference type="PubMed" id="12442251"/>
<dbReference type="DOI" id="10.1002/1615-9861(200211)2:11&lt;1516::AID-PROT1516>3.0.CO;2-Y"/>
</citation>
<scope>PHOSPHORYLATION AT SER-335</scope>
</reference>
<reference key="13">
<citation type="journal article" date="2003" name="Dev. Cell" volume="5" first="113" last="125">
<title>Polo-like kinase 1 regulates Nlp, a centrosome protein involved in microtubule nucleation.</title>
<authorList>
<person name="Casenghi M."/>
<person name="Meraldi P."/>
<person name="Weinhart U."/>
<person name="Duncan P.I."/>
<person name="Korner R."/>
<person name="Nigg E.A."/>
</authorList>
<dbReference type="PubMed" id="12852856"/>
<dbReference type="DOI" id="10.1016/S1534-5807(03)00193-X"/>
</citation>
<scope>FUNCTION IN PHOSPHORYLATION OF NINL</scope>
</reference>
<reference key="14">
<citation type="journal article" date="2003" name="J. Biol. Chem." volume="278" first="18221" last="18228">
<title>Stk10, a new member of the polo-like kinase kinase family highly expressed in hematopoietic tissue.</title>
<authorList>
<person name="Walter S.A."/>
<person name="Cutler R.E. Jr."/>
<person name="Martinez R."/>
<person name="Gishizky M."/>
<person name="Hill R.J."/>
</authorList>
<dbReference type="PubMed" id="12639966"/>
<dbReference type="DOI" id="10.1074/jbc.M212556200"/>
</citation>
<scope>PHOSPHORYLATION BY STK10</scope>
</reference>
<reference key="15">
<citation type="journal article" date="2003" name="J. Biol. Chem." volume="278" first="25277" last="25280">
<title>Identification of a consensus motif for Plk (Polo-like kinase) phosphorylation reveals Myt1 as a Plk1 substrate.</title>
<authorList>
<person name="Nakajima H."/>
<person name="Toyoshima-Morimoto F."/>
<person name="Taniguchi E."/>
<person name="Nishida E."/>
</authorList>
<dbReference type="PubMed" id="12738781"/>
<dbReference type="DOI" id="10.1074/jbc.C300126200"/>
</citation>
<scope>FUNCTION IN PHOSPHORYLATION OF PKMYT1</scope>
</reference>
<reference key="16">
<citation type="journal article" date="2003" name="J. Cell Biol." volume="162" first="863" last="875">
<title>Phosphorylation of mitotic kinesin-like protein 2 by polo-like kinase 1 is required for cytokinesis.</title>
<authorList>
<person name="Neef R."/>
<person name="Preisinger C."/>
<person name="Sutcliffe J."/>
<person name="Kopajtich R."/>
<person name="Nigg E.A."/>
<person name="Mayer T.U."/>
<person name="Barr F.A."/>
</authorList>
<dbReference type="PubMed" id="12939256"/>
<dbReference type="DOI" id="10.1083/jcb.200306009"/>
</citation>
<scope>FUNCTION IN PHOSPHORYLATION OF KIF20A</scope>
<scope>DOMAIN POLO BOX</scope>
<scope>SUBCELLULAR LOCATION</scope>
<scope>INTERACTION WITH KIF20A</scope>
</reference>
<reference key="17">
<citation type="journal article" date="2003" name="Nat. Cell Biol." volume="5" first="143" last="148">
<title>Active cyclin B1-Cdk1 first appears on centrosomes in prophase.</title>
<authorList>
<person name="Jackman M."/>
<person name="Lindon C."/>
<person name="Nigg E.A."/>
<person name="Pines J."/>
</authorList>
<dbReference type="PubMed" id="12524548"/>
<dbReference type="DOI" id="10.1038/ncb918"/>
</citation>
<scope>FUNCTION IN PHOSPHORYLATION OF CCNB1</scope>
<scope>SUBCELLULAR LOCATION</scope>
</reference>
<reference key="18">
<citation type="journal article" date="2004" name="J. Cell Biol." volume="164" first="233" last="241">
<title>Ordered proteolysis in anaphase inactivates Plk1 to contribute to proper mitotic exit in human cells.</title>
<authorList>
<person name="Lindon C."/>
<person name="Pines J."/>
</authorList>
<dbReference type="PubMed" id="14734534"/>
<dbReference type="DOI" id="10.1083/jcb.200309035"/>
</citation>
<scope>FUNCTION</scope>
<scope>PROTEASOMAL DEGRADATION</scope>
<scope>DOMAIN D-BOX MOTIF</scope>
<scope>MUTAGENESIS OF ARG-337 AND LEU-340</scope>
</reference>
<reference key="19">
<citation type="journal article" date="2004" name="Mol. Biol. Cell" volume="15" first="5623" last="5634">
<title>Plk1 regulates activation of the anaphase promoting complex by phosphorylating and triggering SCFbetaTrCP-dependent destruction of the APC inhibitor Emi1.</title>
<authorList>
<person name="Hansen D.V."/>
<person name="Loktev A.V."/>
<person name="Ban K.H."/>
<person name="Jackson P.K."/>
</authorList>
<dbReference type="PubMed" id="15469984"/>
<dbReference type="DOI" id="10.1091/mbc.E04-07-0598"/>
</citation>
<scope>FUNCTION IN PHOSPHORYLATION OF FBXO5</scope>
</reference>
<reference key="20">
<citation type="journal article" date="2004" name="Proc. Natl. Acad. Sci. U.S.A." volume="101" first="4419" last="4424">
<title>M-phase kinases induce phospho-dependent ubiquitination of somatic Wee1 by SCFbeta-TrCP.</title>
<authorList>
<person name="Watanabe N."/>
<person name="Arai H."/>
<person name="Nishihara Y."/>
<person name="Taniguchi M."/>
<person name="Watanabe N."/>
<person name="Hunter T."/>
<person name="Osada H."/>
</authorList>
<dbReference type="PubMed" id="15070733"/>
<dbReference type="DOI" id="10.1073/pnas.0307700101"/>
</citation>
<scope>FUNCTION IN PHOSPHORYLATION OF WEE1</scope>
</reference>
<reference key="21">
<citation type="journal article" date="2004" name="Proc. Natl. Acad. Sci. U.S.A." volume="101" first="7937" last="7942">
<title>Role of Polo-like kinase in the degradation of early mitotic inhibitor 1, a regulator of the anaphase promoting complex/cyclosome.</title>
<authorList>
<person name="Moshe Y."/>
<person name="Boulaire J."/>
<person name="Pagano M."/>
<person name="Hershko A."/>
</authorList>
<dbReference type="PubMed" id="15148369"/>
<dbReference type="DOI" id="10.1073/pnas.0402442101"/>
</citation>
<scope>FUNCTION IN PHOSPHORYLATION OF FBXO5</scope>
</reference>
<reference key="22">
<citation type="journal article" date="2005" name="Dev. Cell" volume="9" first="477" last="488">
<title>Cdk1/Erk2- and Plk1-dependent phosphorylation of a centrosome protein, Cep55, is required for its recruitment to midbody and cytokinesis.</title>
<authorList>
<person name="Fabbro M."/>
<person name="Zhou B.-B."/>
<person name="Takahashi M."/>
<person name="Sarcevic B."/>
<person name="Lal P."/>
<person name="Graham M.E."/>
<person name="Gabrielli B.G."/>
<person name="Robinson P.J."/>
<person name="Nigg E.A."/>
<person name="Ono Y."/>
<person name="Khanna K.K."/>
</authorList>
<dbReference type="PubMed" id="16198290"/>
<dbReference type="DOI" id="10.1016/j.devcel.2005.09.003"/>
</citation>
<scope>FUNCTION IN PHOSPHORYLATION OF CEP55</scope>
</reference>
<reference key="23">
<citation type="journal article" date="2005" name="J. Biol. Chem." volume="280" first="12653" last="12657">
<title>Polo-like kinase 1 phosphorylates heat shock transcription factor 1 and mediates its nuclear translocation during heat stress.</title>
<authorList>
<person name="Kim S.A."/>
<person name="Yoon J.H."/>
<person name="Lee S.H."/>
<person name="Ahn S.G."/>
</authorList>
<dbReference type="PubMed" id="15661742"/>
<dbReference type="DOI" id="10.1074/jbc.M411908200"/>
</citation>
<scope>FUNCTION IN PHOSPHORYLATION OF HSF1</scope>
<scope>INTERACTION WITH HSF1</scope>
</reference>
<reference key="24">
<citation type="journal article" date="2005" name="Mol. Biol. Cell" volume="16" first="1095" last="1107">
<title>The forkhead-associated domain protein Cep170 interacts with Polo-like kinase 1 and serves as a marker for mature centrioles.</title>
<authorList>
<person name="Guarguaglini G."/>
<person name="Duncan P.I."/>
<person name="Stierhof Y.D."/>
<person name="Holmstroem T."/>
<person name="Duensing S."/>
<person name="Nigg E.A."/>
</authorList>
<dbReference type="PubMed" id="15616186"/>
<dbReference type="DOI" id="10.1091/mbc.E04-10-0939"/>
</citation>
<scope>INTERACTION WITH CEP170</scope>
</reference>
<reference key="25">
<citation type="journal article" date="2006" name="Cell" volume="124" first="367" last="380">
<title>The evi5 oncogene regulates cyclin accumulation by stabilizing the anaphase-promoting complex inhibitor emi1.</title>
<authorList>
<person name="Eldridge A.G."/>
<person name="Loktev A.V."/>
<person name="Hansen D.V."/>
<person name="Verschuren E.W."/>
<person name="Reimann J.D.R."/>
<person name="Jackson P.K."/>
</authorList>
<dbReference type="PubMed" id="16439210"/>
<dbReference type="DOI" id="10.1016/j.cell.2005.10.038"/>
</citation>
<scope>INTERACTION WITH EVI5</scope>
</reference>
<reference key="26">
<citation type="journal article" date="2006" name="Mol. Biol. Cell" volume="17" first="3705" last="3716">
<title>Phosphorylation- and polo-box-dependent binding of Plk1 to Bub1 is required for the kinetochore localization of Plk1.</title>
<authorList>
<person name="Qi W."/>
<person name="Tang Z."/>
<person name="Yu H."/>
</authorList>
<dbReference type="PubMed" id="16760428"/>
<dbReference type="DOI" id="10.1091/mbc.E06-03-0240"/>
</citation>
<scope>SUBCELLULAR LOCATION</scope>
<scope>INTERACTION WITH BUB1 AND BUB1B</scope>
<scope>MUTAGENESIS OF HIS-538 AND LYS-540</scope>
</reference>
<reference key="27">
<citation type="journal article" date="2006" name="Nat. Cell Biol." volume="8" first="1095" last="1101">
<title>The Plk1 target Kizuna stabilizes mitotic centrosomes to ensure spindle bipolarity.</title>
<authorList>
<person name="Oshimori N."/>
<person name="Ohsugi M."/>
<person name="Yamamoto T."/>
</authorList>
<dbReference type="PubMed" id="16980960"/>
<dbReference type="DOI" id="10.1038/ncb1474"/>
</citation>
<scope>FUNCTION IN PHOSPHORYLATION OF KIZ</scope>
</reference>
<reference key="28">
<citation type="journal article" date="2006" name="Oncogene" volume="25" first="827" last="837">
<title>Phosphorylation of the cytokinesis regulator ECT2 at G2/M phase stimulates association of the mitotic kinase Plk1 and accumulation of GTP-bound RhoA.</title>
<authorList>
<person name="Niiya F."/>
<person name="Tatsumoto T."/>
<person name="Lee K.S."/>
<person name="Miki T."/>
</authorList>
<dbReference type="PubMed" id="16247472"/>
<dbReference type="DOI" id="10.1038/sj.onc.1209124"/>
</citation>
<scope>FUNCTION IN PHOSPHORYLATION OF ECT2</scope>
<scope>INTERACTION WITH ECT2</scope>
</reference>
<reference key="29">
<citation type="journal article" date="2006" name="Mol. Cell" volume="24" first="409" last="422">
<title>Self-regulated Plk1 recruitment to kinetochores by the Plk1-PBIP1 interaction is critical for proper chromosome segregation.</title>
<authorList>
<person name="Kang Y.H."/>
<person name="Park J.-E."/>
<person name="Yu L.-R."/>
<person name="Soung N.-K."/>
<person name="Yun S.-M."/>
<person name="Bang J.K."/>
<person name="Seong Y.-S."/>
<person name="Yu H."/>
<person name="Garfield S."/>
<person name="Veenstra T.D."/>
<person name="Lee K.S."/>
</authorList>
<dbReference type="PubMed" id="17081991"/>
<dbReference type="DOI" id="10.1016/j.molcel.2006.10.016"/>
</citation>
<scope>FUNCTION IN PHOSPHORYLATION OF CENPU</scope>
</reference>
<reference key="30">
<citation type="journal article" date="2006" name="Oncology" volume="70" first="126" last="133">
<title>Expression of polo-like kinase 1 (PLK1) protein predicts the survival of patients with gastric carcinoma.</title>
<authorList>
<person name="Kanaji S."/>
<person name="Saito H."/>
<person name="Tsujitani S."/>
<person name="Matsumoto S."/>
<person name="Tatebe S."/>
<person name="Kondo A."/>
<person name="Ozaki M."/>
<person name="Ito H."/>
<person name="Ikeguchi M."/>
</authorList>
<dbReference type="PubMed" id="16645325"/>
<dbReference type="DOI" id="10.1159/000093003"/>
</citation>
<scope>INVOLVEMENT IN CANCER</scope>
</reference>
<reference key="31">
<citation type="journal article" date="2007" name="Cancer Res." volume="67" first="10148" last="10158">
<title>A cell proliferation and chromosomal instability signature in anaplastic thyroid carcinoma.</title>
<authorList>
<person name="Salvatore G."/>
<person name="Nappi T.C."/>
<person name="Salerno P."/>
<person name="Jiang Y."/>
<person name="Garbi C."/>
<person name="Ugolini C."/>
<person name="Miccoli P."/>
<person name="Basolo F."/>
<person name="Castellone M.D."/>
<person name="Cirafici A.M."/>
<person name="Melillo R.M."/>
<person name="Fusco A."/>
<person name="Bittner M.L."/>
<person name="Santoro M."/>
</authorList>
<dbReference type="PubMed" id="17981789"/>
<dbReference type="DOI" id="10.1158/0008-5472.CAN-07-1887"/>
</citation>
<scope>INVOLVEMENT IN CANCER</scope>
</reference>
<reference key="32">
<citation type="journal article" date="2007" name="Cell" volume="128" first="101" last="114">
<title>PICH, a centromere-associated SNF2 family ATPase, is regulated by Plk1 and required for the spindle checkpoint.</title>
<authorList>
<person name="Baumann C."/>
<person name="Koerner R."/>
<person name="Hofmann K."/>
<person name="Nigg E.A."/>
</authorList>
<dbReference type="PubMed" id="17218258"/>
<dbReference type="DOI" id="10.1016/j.cell.2006.11.041"/>
</citation>
<scope>INTERACTION WITH ERCC6L</scope>
</reference>
<reference key="33">
<citation type="journal article" date="2007" name="Cell Cycle" volume="6" first="1579" last="1585">
<title>Shugoshin 1 plays a central role in kinetochore assembly and is required for kinetochore targeting of Plk1.</title>
<authorList>
<person name="Pouwels J."/>
<person name="Kukkonen A.M."/>
<person name="Lan W."/>
<person name="Daum J.R."/>
<person name="Gorbsky G.J."/>
<person name="Stukenberg T."/>
<person name="Kallio M.J."/>
</authorList>
<dbReference type="PubMed" id="17617734"/>
<dbReference type="DOI" id="10.4161/cc.6.13.4442"/>
</citation>
<scope>FUNCTION</scope>
<scope>SUBCELLULAR LOCATION</scope>
</reference>
<reference key="34">
<citation type="journal article" date="2007" name="Cell. Mol. Life Sci." volume="64" first="632" last="640">
<title>TTDN1 is a Plk1-interacting protein involved in maintenance of cell cycle integrity.</title>
<authorList>
<person name="Zhang Y."/>
<person name="Tian Y."/>
<person name="Chen Q."/>
<person name="Chen D."/>
<person name="Zhai Z."/>
<person name="Shu H.-B."/>
</authorList>
<dbReference type="PubMed" id="17310276"/>
<dbReference type="DOI" id="10.1007/s00018-007-6501-8"/>
</citation>
<scope>INTERACTION WITH TTDN1</scope>
</reference>
<reference key="35">
<citation type="journal article" date="2007" name="J. Biol. Chem." volume="282" first="15217" last="15227">
<title>Polo-like kinase 1 facilitates chromosome alignment during prometaphase through BubR1.</title>
<authorList>
<person name="Matsumura S."/>
<person name="Toyoshima F."/>
<person name="Nishida E."/>
</authorList>
<dbReference type="PubMed" id="17376779"/>
<dbReference type="DOI" id="10.1074/jbc.M611053200"/>
</citation>
<scope>FUNCTION IN PHOSPHORYLATION OF BUB1B</scope>
</reference>
<reference key="36">
<citation type="journal article" date="2007" name="Leuk. Lymphoma" volume="48" first="2179" last="2183">
<title>Expression of PLK1 and survivin in diffuse large B-cell lymphoma.</title>
<authorList>
<person name="Liu L."/>
<person name="Zhang M."/>
<person name="Zou P."/>
</authorList>
<dbReference type="PubMed" id="17943598"/>
<dbReference type="DOI" id="10.1080/10428190701615918"/>
</citation>
<scope>INVOLVEMENT IN CANCER</scope>
</reference>
<reference key="37">
<citation type="journal article" date="2007" name="Nat. Cell Biol." volume="9" first="436" last="444">
<title>Choice of Plk1 docking partners during mitosis and cytokinesis is controlled by the activation state of Cdk1.</title>
<authorList>
<person name="Neef R."/>
<person name="Gruneberg U."/>
<person name="Kopajtich R."/>
<person name="Li X."/>
<person name="Nigg E.A."/>
<person name="Sillje H."/>
<person name="Barr F.A."/>
</authorList>
<dbReference type="PubMed" id="17351640"/>
<dbReference type="DOI" id="10.1038/ncb1557"/>
</citation>
<scope>FUNCTION IN PHOSPHORYLATION OF PRC1</scope>
<scope>DOMAIN POLO BOX</scope>
</reference>
<reference key="38">
<citation type="journal article" date="2007" name="Proc. Natl. Acad. Sci. U.S.A." volume="104" first="8869" last="8874">
<title>The tumor suppressor CYLD regulates entry into mitosis.</title>
<authorList>
<person name="Stegmeier F."/>
<person name="Sowa M.E."/>
<person name="Nalepa G."/>
<person name="Gygi S.P."/>
<person name="Harper J.W."/>
<person name="Elledge S.J."/>
</authorList>
<dbReference type="PubMed" id="17495026"/>
<dbReference type="DOI" id="10.1073/pnas.0703268104"/>
</citation>
<scope>INTERACTION WITH CYLD</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY</scope>
</reference>
<reference key="39">
<citation type="journal article" date="2008" name="Cancer Res." volume="68" first="7550" last="7560">
<title>HSF1 as a mitotic regulator: phosphorylation of HSF1 by Plk1 is essential for mitotic progression.</title>
<authorList>
<person name="Lee Y.J."/>
<person name="Kim E.H."/>
<person name="Lee J.S."/>
<person name="Jeoung D."/>
<person name="Bae S."/>
<person name="Kwon S.H."/>
<person name="Lee Y.S."/>
</authorList>
<dbReference type="PubMed" id="18794143"/>
<dbReference type="DOI" id="10.1158/0008-5472.CAN-08-0129"/>
</citation>
<scope>FUNCTION IN PHOSPHORYLATION OF HSF1</scope>
<scope>INTERACTION WITH HSF1</scope>
<scope>SUBCELLULAR LOCATION</scope>
</reference>
<reference key="40">
<citation type="journal article" date="2008" name="Cell" volume="134" first="256" last="267">
<title>The Cdc14B-Cdh1-Plk1 axis controls the G2 DNA-damage-response checkpoint.</title>
<authorList>
<person name="Bassermann F."/>
<person name="Frescas D."/>
<person name="Guardavaccaro D."/>
<person name="Busino L."/>
<person name="Peschiaroli A."/>
<person name="Pagano M."/>
</authorList>
<dbReference type="PubMed" id="18662541"/>
<dbReference type="DOI" id="10.1016/j.cell.2008.05.043"/>
</citation>
<scope>UBIQUITINATION BY THE APC/C COMPLEX</scope>
<scope>INTERACTION WITH FZR1</scope>
<scope>MUTAGENESIS OF ARG-337 AND LEU-340</scope>
</reference>
<reference key="41">
<citation type="journal article" date="2008" name="Cell" volume="132" first="832" last="845">
<title>Final stages of cytokinesis and midbody ring formation are controlled by BRUCE.</title>
<authorList>
<person name="Pohl C."/>
<person name="Jentsch S."/>
</authorList>
<dbReference type="PubMed" id="18329369"/>
<dbReference type="DOI" id="10.1016/j.cell.2008.01.012"/>
</citation>
<scope>INTERACTION WITH BIRC6/BRUCE</scope>
</reference>
<reference key="42">
<citation type="journal article" date="2008" name="Cell Cycle" volume="7" first="1214" last="1223">
<title>p73-mediated transcriptional activity is negatively regulated by polo-like kinase 1.</title>
<authorList>
<person name="Soond S.M."/>
<person name="Barry S.P."/>
<person name="Melino G."/>
<person name="Knight R.A."/>
<person name="Latchman D.S."/>
<person name="Stephanou A."/>
</authorList>
<dbReference type="PubMed" id="18418051"/>
<dbReference type="DOI" id="10.4161/cc.7.9.5777"/>
</citation>
<scope>FUNCTION IN PHOSPHORYLATION OF TP73</scope>
</reference>
<reference key="43">
<citation type="journal article" date="2008" name="Chromosoma" volume="117" first="457" last="469">
<title>Plk1 regulates mitotic Aurora A function through betaTrCP-dependent degradation of hBora.</title>
<authorList>
<person name="Chan E.H."/>
<person name="Santamaria A."/>
<person name="Sillje H.H."/>
<person name="Nigg E.A."/>
</authorList>
<dbReference type="PubMed" id="18521620"/>
<dbReference type="DOI" id="10.1007/s00412-008-0165-5"/>
</citation>
<scope>FUNCTION</scope>
<scope>INTERACTION WITH PHOSPHORYLATED BORA</scope>
</reference>
<reference key="44">
<citation type="journal article" date="2008" name="Dev. Cell" volume="14" first="331" last="341">
<title>sSgo1, a major splice variant of Sgo1, functions in centriole cohesion where it is regulated by Plk1.</title>
<authorList>
<person name="Wang X."/>
<person name="Yang Y."/>
<person name="Duan Q."/>
<person name="Jiang N."/>
<person name="Huang Y."/>
<person name="Darzynkiewicz Z."/>
<person name="Dai W."/>
</authorList>
<dbReference type="PubMed" id="18331714"/>
<dbReference type="DOI" id="10.1016/j.devcel.2007.12.007"/>
</citation>
<scope>FUNCTION IN PHOSPHORYLATION OF SGO1</scope>
<scope>INTERACTION WITH SGO1</scope>
</reference>
<reference key="45">
<citation type="journal article" date="2008" name="Dev. Cell" volume="14" first="787" last="797">
<title>Myosin phosphatase-targeting subunit 1 regulates mitosis by antagonizing polo-like kinase 1.</title>
<authorList>
<person name="Yamashiro S."/>
<person name="Yamakita Y."/>
<person name="Totsukawa G."/>
<person name="Goto H."/>
<person name="Kaibuchi K."/>
<person name="Ito M."/>
<person name="Hartshorne D.J."/>
<person name="Matsumura F."/>
</authorList>
<dbReference type="PubMed" id="18477460"/>
<dbReference type="DOI" id="10.1016/j.devcel.2008.02.013"/>
</citation>
<scope>FUNCTION IN PHOSPHORYLATION OF PPP1R12A</scope>
<scope>PHOSPHORYLATION AT THR-210</scope>
<scope>DEPHOSPHORYLATION BY PPP1C</scope>
<scope>SUBCELLULAR LOCATION</scope>
<scope>MUTAGENESIS OF HIS-538 AND LYS-540</scope>
</reference>
<reference key="46">
<citation type="journal article" date="2008" name="J. Biol. Chem." volume="283" first="8555" last="8563">
<title>Inhibitory role of Plk1 in the regulation of p73-dependent apoptosis through physical interaction and phosphorylation.</title>
<authorList>
<person name="Koida N."/>
<person name="Ozaki T."/>
<person name="Yamamoto H."/>
<person name="Ono S."/>
<person name="Koda T."/>
<person name="Ando K."/>
<person name="Okoshi R."/>
<person name="Kamijo T."/>
<person name="Omura K."/>
<person name="Nakagawara A."/>
</authorList>
<dbReference type="PubMed" id="18174154"/>
<dbReference type="DOI" id="10.1074/jbc.M710608200"/>
</citation>
<scope>FUNCTION IN PHOSPHORYLATION OF TP73</scope>
<scope>MUTAGENESIS OF LYS-82</scope>
</reference>
<reference key="47">
<citation type="journal article" date="2008" name="J. Cell Biol." volume="183" first="835" last="848">
<title>FAM29A promotes microtubule amplification via recruitment of the NEDD1-gamma-tubulin complex to the mitotic spindle.</title>
<authorList>
<person name="Zhu H."/>
<person name="Coppinger J.A."/>
<person name="Jang C.-Y."/>
<person name="Yates J.R. III"/>
<person name="Fang G."/>
</authorList>
<dbReference type="PubMed" id="19029337"/>
<dbReference type="DOI" id="10.1083/jcb.200807046"/>
</citation>
<scope>INTERACTION WITH FAM29A</scope>
</reference>
<reference key="48">
<citation type="journal article" date="2008" name="Mol. Cell" volume="31" first="438" last="448">
<title>Kinase-selective enrichment enables quantitative phosphoproteomics of the kinome across the cell cycle.</title>
<authorList>
<person name="Daub H."/>
<person name="Olsen J.V."/>
<person name="Bairlein M."/>
<person name="Gnad F."/>
<person name="Oppermann F.S."/>
<person name="Korner R."/>
<person name="Greff Z."/>
<person name="Keri G."/>
<person name="Stemmann O."/>
<person name="Mann M."/>
</authorList>
<dbReference type="PubMed" id="18691976"/>
<dbReference type="DOI" id="10.1016/j.molcel.2008.07.007"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-6; SER-103; THR-210; THR-214; SER-375; SER-450 AND THR-498</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Cervix carcinoma</tissue>
</source>
</reference>
<reference key="49">
<citation type="journal article" date="2008" name="Nat. Cell Biol." volume="10" first="1076" last="1082">
<title>Plk1-dependent phosphorylation of FoxM1 regulates a transcriptional programme required for mitotic progression.</title>
<authorList>
<person name="Fu Z."/>
<person name="Malureanu L."/>
<person name="Huang J."/>
<person name="Wang W."/>
<person name="Li H."/>
<person name="van Deursen J.M."/>
<person name="Tindall D.J."/>
<person name="Chen J."/>
</authorList>
<dbReference type="PubMed" id="19160488"/>
<dbReference type="DOI" id="10.1038/ncb1767"/>
</citation>
<scope>FUNCTION IN PHOSPHORYLATION OF FOXM1</scope>
<scope>MUTAGENESIS OF LYS-82 AND THR-210</scope>
</reference>
<reference key="50">
<citation type="journal article" date="2008" name="Nature" volume="455" first="119" last="123">
<title>Polo-like kinase-1 is activated by aurora A to promote checkpoint recovery.</title>
<authorList>
<person name="Macurek L."/>
<person name="Lindqvist A."/>
<person name="Lim D."/>
<person name="Lampson M.A."/>
<person name="Klompmaker R."/>
<person name="Freire R."/>
<person name="Clouin C."/>
<person name="Taylor S.S."/>
<person name="Yaffe M.B."/>
<person name="Medema R.H."/>
</authorList>
<dbReference type="PubMed" id="18615013"/>
<dbReference type="DOI" id="10.1038/nature07185"/>
</citation>
<scope>FUNCTION</scope>
<scope>ENZYME REGULATION</scope>
<scope>PHOSPHORYLATION AT THR-210 BY AURKA</scope>
<scope>SUBCELLULAR LOCATION</scope>
<scope>MUTAGENESIS OF LYS-82; SER-137; ASP-176 AND THR-210</scope>
</reference>
<reference key="51">
<citation type="journal article" date="2008" name="Proc. Natl. Acad. Sci. U.S.A." volume="105" first="10762" last="10767">
<title>A quantitative atlas of mitotic phosphorylation.</title>
<authorList>
<person name="Dephoure N."/>
<person name="Zhou C."/>
<person name="Villen J."/>
<person name="Beausoleil S.A."/>
<person name="Bakalarski C.E."/>
<person name="Elledge S.J."/>
<person name="Gygi S.P."/>
</authorList>
<dbReference type="PubMed" id="18669648"/>
<dbReference type="DOI" id="10.1073/pnas.0805139105"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-210 AND THR-214</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Cervix carcinoma</tissue>
</source>
</reference>
<reference key="52">
<citation type="journal article" date="2009" name="Cell" volume="138" first="63" last="77">
<title>Mammalian BTBD12/SLX4 assembles a Holliday junction resolvase and is required for DNA repair.</title>
<authorList>
<person name="Svendsen J.M."/>
<person name="Smogorzewska A."/>
<person name="Sowa M.E."/>
<person name="O'Connell B.C."/>
<person name="Gygi S.P."/>
<person name="Elledge S.J."/>
<person name="Harper J.W."/>
</authorList>
<dbReference type="PubMed" id="19596235"/>
<dbReference type="DOI" id="10.1016/j.cell.2009.06.030"/>
</citation>
<scope>INTERACTION WITH SLX4</scope>
</reference>
<reference key="53">
<citation type="journal article" date="2009" name="J. Biol. Chem." volume="284" first="18588" last="18592">
<title>Plk1-mediated phosphorylation of Topors regulates p53 stability.</title>
<authorList>
<person name="Yang X."/>
<person name="Li H."/>
<person name="Zhou Z."/>
<person name="Wang W.H."/>
<person name="Deng A."/>
<person name="Andrisani O."/>
<person name="Liu X."/>
</authorList>
<dbReference type="PubMed" id="19473992"/>
<dbReference type="DOI" id="10.1074/jbc.C109.001560"/>
</citation>
<scope>FUNCTION IN PHOSPHORYLATION OF TOPORS</scope>
<scope>INTERACTION WITH TOPORS</scope>
</reference>
<reference key="54">
<citation type="journal article" date="2009" name="J. Cell Sci." volume="122" first="2240" last="2251">
<title>Sequential phosphorylation of Nedd1 by Cdk1 and Plk1 is required for targeting of the gammaTuRC to the centrosome.</title>
<authorList>
<person name="Zhang X."/>
<person name="Chen Q."/>
<person name="Feng J."/>
<person name="Hou J."/>
<person name="Yang F."/>
<person name="Liu J."/>
<person name="Jiang Q."/>
<person name="Zhang C."/>
</authorList>
<dbReference type="PubMed" id="19509060"/>
<dbReference type="DOI" id="10.1242/jcs.042747"/>
</citation>
<scope>FUNCTION AS NEDD1 KINASE</scope>
</reference>
<reference key="55">
<citation type="journal article" date="2009" name="J. Cell Sci." volume="122" first="1334" last="1341">
<title>Plk1 and Aurora A regulate the depolymerase activity and the cellular localization of Kif2a.</title>
<authorList>
<person name="Jang C.Y."/>
<person name="Coppinger J.A."/>
<person name="Seki A."/>
<person name="Yates J.R. III"/>
<person name="Fang G."/>
</authorList>
<dbReference type="PubMed" id="19351716"/>
<dbReference type="DOI" id="10.1242/jcs.044321"/>
</citation>
<scope>FUNCTION</scope>
<scope>INTERACTION WITH KIF2A</scope>
<scope>SUBCELLULAR LOCATION</scope>
</reference>
<reference key="56">
<citation type="journal article" date="2009" name="Mol. Cell. Proteomics" volume="8" first="1751" last="1764">
<title>Large-scale proteomics analysis of the human kinome.</title>
<authorList>
<person name="Oppermann F.S."/>
<person name="Gnad F."/>
<person name="Olsen J.V."/>
<person name="Hornberger R."/>
<person name="Greff Z."/>
<person name="Keri G."/>
<person name="Mann M."/>
<person name="Daub H."/>
</authorList>
<dbReference type="PubMed" id="19369195"/>
<dbReference type="DOI" id="10.1074/mcp.M800588-MCP200"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-210 AND THR-214</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
</reference>
<reference key="57">
<citation type="journal article" date="2009" name="PLoS Biol." volume="7" first="E1000110" last="E1000110">
<title>Polo-like kinase 1 directs assembly of the HsCyk-4 RhoGAP/Ect2 RhoGEF complex to initiate cleavage furrow formation.</title>
<authorList>
<person name="Wolfe B.A."/>
<person name="Takaki T."/>
<person name="Petronczki M."/>
<person name="Glotzer M."/>
</authorList>
<dbReference type="PubMed" id="19468300"/>
<dbReference type="DOI" id="10.1371/journal.pbio.1000110"/>
</citation>
<scope>FUNCTION IN PHOSPHORYLATION OF RACGAP1</scope>
<scope>INTERACTION WITH PRC1</scope>
<scope>SUBCELLULAR LOCATION</scope>
</reference>
<reference key="58">
<citation type="journal article" date="2009" name="PLoS Biol." volume="7" first="E1000111" last="E1000111">
<title>Plk1 self-organization and priming phosphorylation of HsCYK-4 at the spindle midzone regulate the onset of division in human cells.</title>
<authorList>
<person name="Burkard M.E."/>
<person name="Maciejowski J."/>
<person name="Rodriguez-Bravo V."/>
<person name="Repka M."/>
<person name="Lowery D.M."/>
<person name="Clauser K.R."/>
<person name="Zhang C."/>
<person name="Shokat K.M."/>
<person name="Carr S.A."/>
<person name="Yaffe M.B."/>
<person name="Jallepalli P.V."/>
</authorList>
<dbReference type="PubMed" id="19468302"/>
<dbReference type="DOI" id="10.1371/journal.pbio.1000111"/>
</citation>
<scope>FUNCTION IN PHOSPHORYLATION OF RACGAP1</scope>
<scope>SUBCELLULAR LOCATION</scope>
<scope>MUTAGENESIS OF CYS-67; LEU-130; HIS-538 AND LYS-540</scope>
</reference>
<reference key="59">
<citation type="journal article" date="2010" name="Nat. Rev. Drug Discov." volume="9" first="643" last="660">
<title>Multifaceted polo-like kinases: drug targets and antitargets for cancer therapy.</title>
<authorList>
<person name="Strebhardt K."/>
</authorList>
<dbReference type="PubMed" id="20671765"/>
<dbReference type="DOI" id="10.1038/nrd3184"/>
</citation>
<scope>REVIEW ON FUNCTION</scope>
<scope>REVIEW ON ENZYME REGULATION</scope>
</reference>
<reference key="60">
<citation type="journal article" date="2010" name="Proc. Natl. Acad. Sci. U.S.A." volume="107" first="14633" last="14638">
<title>Polo-like kinase 1 phosphorylation of p150Glued facilitates nuclear envelope breakdown during prophase.</title>
<authorList>
<person name="Li H."/>
<person name="Liu X.S."/>
<person name="Yang X."/>
<person name="Song B."/>
<person name="Wang Y."/>
<person name="Liu X."/>
</authorList>
<dbReference type="PubMed" id="20679239"/>
<dbReference type="DOI" id="10.1073/pnas.1006615107"/>
</citation>
<scope>FUNCTION IN PHOSPHORYLATION OF DCTN1</scope>
<scope>INTERACTION WITH DCTN1</scope>
</reference>
<reference key="61">
<citation type="journal article" date="2010" name="Sci. Signal." volume="3" first="RA3" last="RA3">
<title>Quantitative phosphoproteomics reveals widespread full phosphorylation site occupancy during mitosis.</title>
<authorList>
<person name="Olsen J.V."/>
<person name="Vermeulen M."/>
<person name="Santamaria A."/>
<person name="Kumar C."/>
<person name="Miller M.L."/>
<person name="Jensen L.J."/>
<person name="Gnad F."/>
<person name="Cox J."/>
<person name="Jensen T.S."/>
<person name="Nigg E.A."/>
<person name="Brunak S."/>
<person name="Mann M."/>
</authorList>
<dbReference type="PubMed" id="20068231"/>
<dbReference type="DOI" id="10.1126/scisignal.2000475"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-210</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Cervix carcinoma</tissue>
</source>
</reference>
<reference key="62">
<citation type="journal article" date="2011" name="BMC Syst. Biol." volume="5" first="17" last="17">
<title>Initial characterization of the human central proteome.</title>
<authorList>
<person name="Burkard T.R."/>
<person name="Planyavsky M."/>
<person name="Kaupe I."/>
<person name="Breitwieser F.P."/>
<person name="Buerckstuemmer T."/>
<person name="Bennett K.L."/>
<person name="Superti-Furga G."/>
<person name="Colinge J."/>
</authorList>
<dbReference type="PubMed" id="21269460"/>
<dbReference type="DOI" id="10.1186/1752-0509-5-17"/>
</citation>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
</reference>
<reference key="63">
<citation type="journal article" date="2011" name="J. Cell Biol." volume="192" first="959" last="968">
<title>The astrin-kinastrin/SKAP complex localizes to microtubule plus ends and facilitates chromosome alignment.</title>
<authorList>
<person name="Dunsch A.K."/>
<person name="Linnane E."/>
<person name="Barr F.A."/>
<person name="Gruneberg U."/>
</authorList>
<dbReference type="PubMed" id="21402792"/>
<dbReference type="DOI" id="10.1083/jcb.201008023"/>
</citation>
<scope>IDENTIFICATION IN A COMPLEX WITH KNSTRN; SPAG5; DYNLL1 AND SGO2</scope>
</reference>
<reference key="64">
<citation type="journal article" date="2012" name="J. Biol. Chem." volume="287" first="27670" last="27681">
<title>Furry protein promotes Aurora A-mediated polo-like kinase 1 activation.</title>
<authorList>
<person name="Ikeda M."/>
<person name="Chiba S."/>
<person name="Ohashi K."/>
<person name="Mizuno K."/>
</authorList>
<dbReference type="PubMed" id="22753416"/>
<dbReference type="DOI" id="10.1074/jbc.M112.378968"/>
</citation>
<scope>INTERACTION WITH FRY</scope>
<scope>SUBCELLULAR LOCATION</scope>
<scope>MUTAGENESIS OF ASP-194</scope>
</reference>
<reference key="65">
<citation type="journal article" date="2012" name="Proc. Natl. Acad. Sci. U.S.A." volume="109" first="12449" last="12454">
<title>N-terminal acetylome analyses and functional insights of the N-terminal acetyltransferase NatB.</title>
<authorList>
<person name="Van Damme P."/>
<person name="Lasa M."/>
<person name="Polevoda B."/>
<person name="Gazquez C."/>
<person name="Elosegui-Artola A."/>
<person name="Kim D.S."/>
<person name="De Juan-Pardo E."/>
<person name="Demeyer K."/>
<person name="Hole K."/>
<person name="Larrea E."/>
<person name="Timmerman E."/>
<person name="Prieto J."/>
<person name="Arnesen T."/>
<person name="Sherman F."/>
<person name="Gevaert K."/>
<person name="Aldabe R."/>
</authorList>
<dbReference type="PubMed" id="22814378"/>
<dbReference type="DOI" id="10.1073/pnas.1210303109"/>
</citation>
<scope>ACETYLATION [LARGE SCALE ANALYSIS] AT SER-2</scope>
<scope>CLEAVAGE OF INITIATOR METHIONINE [LARGE SCALE ANALYSIS]</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
</reference>
<reference key="66">
<citation type="journal article" date="2013" name="Cell Res." volume="23" first="1284" last="1295">
<title>Centrosomal protein FOR20 is essential for S-phase progression by recruiting Plk1 to centrosomes.</title>
<authorList>
<person name="Shen M."/>
<person name="Cai Y."/>
<person name="Yang Y."/>
<person name="Yan X."/>
<person name="Liu X."/>
<person name="Zhou T."/>
</authorList>
<dbReference type="PubMed" id="24018379"/>
<dbReference type="DOI" id="10.1038/cr.2013.127"/>
</citation>
<scope>INTERACTION WITH FOPNL</scope>
<scope>SUBCELLULAR LOCATION</scope>
<scope>MUTAGENESIS OF LYS-82; TRP-414; VAL-415 AND LEU-427</scope>
</reference>
<reference key="67">
<citation type="journal article" date="2013" name="EMBO J." volume="32" first="1023" last="1035">
<title>Dynactin helps target Polo-like kinase 1 to kinetochores via its left-handed beta-helical p27 subunit.</title>
<authorList>
<person name="Yeh T.Y."/>
<person name="Kowalska A.K."/>
<person name="Scipioni B.R."/>
<person name="Cheong F.K."/>
<person name="Zheng M."/>
<person name="Derewenda U."/>
<person name="Derewenda Z.S."/>
<person name="Schroer T.A."/>
</authorList>
<dbReference type="PubMed" id="23455152"/>
<dbReference type="DOI" id="10.1038/emboj.2013.30"/>
</citation>
<scope>INTERACTION WITH DCTN6</scope>
<scope>SUBCELLULAR LOCATION</scope>
</reference>
<reference key="68">
<citation type="journal article" date="2013" name="J. Cell Biol." volume="200" first="773" last="787">
<title>MISP is a novel Plk1 substrate required for proper spindle orientation and mitotic progression.</title>
<authorList>
<person name="Zhu M."/>
<person name="Settele F."/>
<person name="Kotak S."/>
<person name="Sanchez-Pulido L."/>
<person name="Ehret L."/>
<person name="Ponting C.P."/>
<person name="Goenczy P."/>
<person name="Hoffmann I."/>
</authorList>
<dbReference type="PubMed" id="23509069"/>
<dbReference type="DOI" id="10.1083/jcb.201207050"/>
</citation>
<scope>FUNCTION IN PHOSPHORYLATION OF MISP</scope>
</reference>
<reference key="69">
<citation type="journal article" date="2013" name="J. Proteome Res." volume="12" first="260" last="271">
<title>Toward a comprehensive characterization of a human cancer cell phosphoproteome.</title>
<authorList>
<person name="Zhou H."/>
<person name="Di Palma S."/>
<person name="Preisinger C."/>
<person name="Peng M."/>
<person name="Polat A.N."/>
<person name="Heck A.J."/>
<person name="Mohammed S."/>
</authorList>
<dbReference type="PubMed" id="23186163"/>
<dbReference type="DOI" id="10.1021/pr300630k"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-210</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Cervix carcinoma</tissue>
<tissue>Erythroleukemia</tissue>
</source>
</reference>
<reference key="70">
<citation type="journal article" date="2013" name="Nat. Cell Biol." volume="15" first="430" last="439">
<title>Ubiquitylation-dependent localization of PLK1 in mitosis.</title>
<authorList>
<person name="Beck J."/>
<person name="Maerki S."/>
<person name="Posch M."/>
<person name="Metzger T."/>
<person name="Persaud A."/>
<person name="Scheel H."/>
<person name="Hofmann K."/>
<person name="Rotin D."/>
<person name="Pedrioli P."/>
<person name="Swedlow J.R."/>
<person name="Peter M."/>
<person name="Sumara I."/>
</authorList>
<dbReference type="PubMed" id="23455478"/>
<dbReference type="DOI" id="10.1038/ncb2695"/>
</citation>
<scope>FUNCTION</scope>
<scope>SUBCELLULAR LOCATION</scope>
<scope>UBIQUITINATION AT LYS-9 AND LYS-492</scope>
<scope>MUTAGENESIS OF LYS-492</scope>
</reference>
<reference key="71">
<citation type="journal article" date="2015" name="Nat. Cell Biol." volume="17" first="31" last="43">
<title>Degradation of Cep68 and PCNT cleavage mediate Cep215 removal from the PCM to allow centriole separation, disengagement and licensing.</title>
<authorList>
<person name="Pagan J.K."/>
<person name="Marzio A."/>
<person name="Jones M.J."/>
<person name="Saraf A."/>
<person name="Jallepalli P.V."/>
<person name="Florens L."/>
<person name="Washburn M.P."/>
<person name="Pagano M."/>
</authorList>
<dbReference type="PubMed" id="25503564"/>
<dbReference type="DOI" id="10.1038/ncb3076"/>
</citation>
<scope>FUNCTION</scope>
<scope>INTERACTION WITH CEP68</scope>
</reference>
<reference key="72">
<citation type="journal article" date="2003" name="Cell" volume="115" first="83" last="95">
<title>The molecular basis for phosphodependent substrate targeting and regulation of Plks by the Polo-box domain.</title>
<authorList>
<person name="Elia A.E."/>
<person name="Rellos P."/>
<person name="Haire L.F."/>
<person name="Chao J.W."/>
<person name="Ivins F.J."/>
<person name="Hoepker K."/>
<person name="Mohammad D."/>
<person name="Cantley L.C."/>
<person name="Smerdon S.J."/>
<person name="Yaffe M.B."/>
</authorList>
<dbReference type="PubMed" id="14532005"/>
<dbReference type="DOI" id="10.1016/S0092-8674(03)00725-6"/>
</citation>
<scope>X-RAY CRYSTALLOGRAPHY (1.9 ANGSTROMS) OF 367-603 IN COMPLEX WITH PHOSPHORYLATED PEPTIDE</scope>
<scope>FUNCTION</scope>
<scope>SUBCELLULAR LOCATION</scope>
<scope>DOMAIN POLO BOX</scope>
<scope>INTERACTION WITH CDC25C</scope>
<scope>MUTAGENESIS OF HIS-538 AND LYS-540</scope>
</reference>
<reference key="73">
<citation type="journal article" date="2003" name="EMBO J." volume="22" first="5757" last="5768">
<title>The crystal structure of the human polo-like kinase-1 polo box domain and its phospho-peptide complex.</title>
<authorList>
<person name="Cheng K.Y."/>
<person name="Lowe E.D."/>
<person name="Sinclair J."/>
<person name="Nigg E.A."/>
<person name="Johnson L.N."/>
</authorList>
<dbReference type="PubMed" id="14592974"/>
<dbReference type="DOI" id="10.1093/emboj/cdg558"/>
</citation>
<scope>X-RAY CRYSTALLOGRAPHY (2.2 ANGSTROMS) OF 367-603 IN COMPLEX WITH PHOSPHORYLATED PEPTIDE</scope>
</reference>
<reference key="74">
<citation type="journal article" date="2007" name="Biochemistry" volume="46" first="5960" last="5971">
<title>Structure of the catalytic domain of human polo-like kinase 1.</title>
<authorList>
<person name="Kothe M."/>
<person name="Kohls D."/>
<person name="Low S."/>
<person name="Coli R."/>
<person name="Cheng A.C."/>
<person name="Jacques S.L."/>
<person name="Johnson T.L."/>
<person name="Lewis C."/>
<person name="Loh C."/>
<person name="Nonomiya J."/>
<person name="Sheils A.L."/>
<person name="Verdries K.A."/>
<person name="Wynn T.A."/>
<person name="Kuhn C."/>
<person name="Ding Y.H."/>
</authorList>
<dbReference type="PubMed" id="17461553"/>
<dbReference type="DOI" id="10.1021/bi602474j"/>
</citation>
<scope>X-RAY CRYSTALLOGRAPHY (2.4 ANGSTROMS) OF 13-345 OF MUTANT VAL-210 IN COMPLEXES WITH ATP ANALOGS</scope>
<scope>MUTAGENESIS OF THR-210</scope>
</reference>
<reference key="75">
<citation type="journal article" date="2007" name="Chem. Biol. Drug Des." volume="70" first="540" last="546">
<title>Selectivity-determining residues in Plk1.</title>
<authorList>
<person name="Kothe M."/>
<person name="Kohls D."/>
<person name="Low S."/>
<person name="Coli R."/>
<person name="Rennie G.R."/>
<person name="Feru F."/>
<person name="Kuhn C."/>
<person name="Ding Y.H."/>
</authorList>
<dbReference type="PubMed" id="18005335"/>
<dbReference type="DOI" id="10.1111/j.1747-0285.2007.00594.x"/>
</citation>
<scope>X-RAY CRYSTALLOGRAPHY (1.95 ANGSTROMS) OF 37-330 IN COMPLEX WITH SYNTHETIC INHIBITOR BI 2536</scope>
</reference>
<reference key="76">
<citation type="journal article" date="2007" name="Proc. Natl. Acad. Sci. U.S.A." volume="104" first="3107" last="3112">
<title>Molecular and structural basis of polo-like kinase 1 substrate recognition: Implications in centrosomal localization.</title>
<authorList>
<person name="Garcia-Alvarez B."/>
<person name="de Carcer G."/>
<person name="Ibanez S."/>
<person name="Bragado-Nilsson E."/>
<person name="Montoya G."/>
</authorList>
<dbReference type="PubMed" id="17307877"/>
<dbReference type="DOI" id="10.1073/pnas.0609131104"/>
</citation>
<scope>X-RAY CRYSTALLOGRAPHY (1.95 ANGSTROMS) OF 365-603 IN COMPLEX WITH CDC25C</scope>
<scope>SUBCELLULAR LOCATION</scope>
<scope>INTERACTION WITH CDC25C</scope>
<scope>ENZYME REGULATION</scope>
<scope>MUTAGENESIS OF TRP-414</scope>
</reference>
<reference key="77">
<citation type="journal article" date="2008" name="Acta Crystallogr. D" volume="64" first="339" last="353">
<title>Structure of wild-type Plk-1 kinase domain in complex with a selective DARPin.</title>
<authorList>
<person name="Bandeiras T.M."/>
<person name="Hillig R.C."/>
<person name="Matias P.M."/>
<person name="Eberspaecher U."/>
<person name="Fanghanel J."/>
<person name="Thomaz M."/>
<person name="Miranda S."/>
<person name="Crusius K."/>
<person name="Putter V."/>
<person name="Amstutz P."/>
<person name="Gulotti-Georgieva M."/>
<person name="Binz H.K."/>
<person name="Holz C."/>
<person name="Schmitz A.A."/>
<person name="Lang C."/>
<person name="Donner P."/>
<person name="Egner U."/>
<person name="Carrondo M.A."/>
<person name="Muller-Tiemann B."/>
</authorList>
<dbReference type="PubMed" id="18391401"/>
<dbReference type="DOI" id="10.1107/S0907444907068217"/>
</citation>
<scope>X-RAY CRYSTALLOGRAPHY (2.3 ANGSTROMS) OF 33-345 IN COMPLEX WITH A DARPIN</scope>
</reference>
<reference key="78">
<citation type="journal article" date="2009" name="Nat. Struct. Mol. Biol." volume="16" first="876" last="882">
<title>Structural and functional analyses of minimal phosphopeptides targeting the polo-box domain of polo-like kinase 1.</title>
<authorList>
<person name="Yun S.M."/>
<person name="Moulaei T."/>
<person name="Lim D."/>
<person name="Bang J.K."/>
<person name="Park J.E."/>
<person name="Shenoy S.R."/>
<person name="Liu F."/>
<person name="Kang Y.H."/>
<person name="Liao C."/>
<person name="Soung N.K."/>
<person name="Lee S."/>
<person name="Yoon D.Y."/>
<person name="Lim Y."/>
<person name="Lee D.H."/>
<person name="Otaka A."/>
<person name="Appella E."/>
<person name="McMahon J.B."/>
<person name="Nicklaus M.C."/>
<person name="Burke T.R. Jr."/>
<person name="Yaffe M.B."/>
<person name="Wlodawer A."/>
<person name="Lee K.S."/>
</authorList>
<dbReference type="PubMed" id="19597481"/>
<dbReference type="DOI" id="10.1038/nsmb.1628"/>
</citation>
<scope>X-RAY CRYSTALLOGRAPHY (1.58 ANGSTROMS) OF 371-603 IN COMPLEX WITH PHOSPHOPEPTIDE</scope>
<scope>FUNCTION</scope>
<scope>SUBCELLULAR LOCATION</scope>
<scope>INTERACTION WITH PHOSPHORYLATED CENPU</scope>
</reference>
<reference key="79">
<citation type="journal article" date="2007" name="Nature" volume="446" first="153" last="158">
<title>Patterns of somatic mutation in human cancer genomes.</title>
<authorList>
<person name="Greenman C."/>
<person name="Stephens P."/>
<person name="Smith R."/>
<person name="Dalgliesh G.L."/>
<person name="Hunter C."/>
<person name="Bignell G."/>
<person name="Davies H."/>
<person name="Teague J."/>
<person name="Butler A."/>
<person name="Stevens C."/>
<person name="Edkins S."/>
<person name="O'Meara S."/>
<person name="Vastrik I."/>
<person name="Schmidt E.E."/>
<person name="Avis T."/>
<person name="Barthorpe S."/>
<person name="Bhamra G."/>
<person name="Buck G."/>
<person name="Choudhury B."/>
<person name="Clements J."/>
<person name="Cole J."/>
<person name="Dicks E."/>
<person name="Forbes S."/>
<person name="Gray K."/>
<person name="Halliday K."/>
<person name="Harrison R."/>
<person name="Hills K."/>
<person name="Hinton J."/>
<person name="Jenkinson A."/>
<person name="Jones D."/>
<person name="Menzies A."/>
<person name="Mironenko T."/>
<person name="Perry J."/>
<person name="Raine K."/>
<person name="Richardson D."/>
<person name="Shepherd R."/>
<person name="Small A."/>
<person name="Tofts C."/>
<person name="Varian J."/>
<person name="Webb T."/>
<person name="West S."/>
<person name="Widaa S."/>
<person name="Yates A."/>
<person name="Cahill D.P."/>
<person name="Louis D.N."/>
<person name="Goldstraw P."/>
<person name="Nicholson A.G."/>
<person name="Brasseur F."/>
<person name="Looijenga L."/>
<person name="Weber B.L."/>
<person name="Chiew Y.-E."/>
<person name="DeFazio A."/>
<person name="Greaves M.F."/>
<person name="Green A.R."/>
<person name="Campbell P."/>
<person name="Birney E."/>
<person name="Easton D.F."/>
<person name="Chenevix-Trench G."/>
<person name="Tan M.-H."/>
<person name="Khoo S.K."/>
<person name="Teh B.T."/>
<person name="Yuen S.T."/>
<person name="Leung S.Y."/>
<person name="Wooster R."/>
<person name="Futreal P.A."/>
<person name="Stratton M.R."/>
</authorList>
<dbReference type="PubMed" id="17344846"/>
<dbReference type="DOI" id="10.1038/nature05610"/>
</citation>
<scope>VARIANTS [LARGE SCALE ANALYSIS] LEU-12; PHE-261; VAL-332; HIS-463 AND HIS-518</scope>
</reference>
<comment type="function">
<text evidence="16 19 20 22 23 25 26 27 28 30 31 32 33 35 36 37 40 41 46 47 50 52 54 56 57 58 59 61 63 64 65 66 67 68 70 71 75 76 78 79">Serine/threonine-protein kinase that performs several important functions throughout M phase of the cell cycle, including the regulation of centrosome maturation and spindle assembly, the removal of cohesins from chromosome arms, the inactivation of anaphase-promoting complex/cyclosome (APC/C) inhibitors, and the regulation of mitotic exit and cytokinesis. Polo-like kinase proteins acts by binding and phosphorylating proteins are that already phosphorylated on a specific motif recognized by the POLO box domains. Phosphorylates BORA, BUB1B/BUBR1, CCNB1, CDC25C, CEP55, ECT2, ERCC6L, FBXO5/EMI1, FOXM1, KIF20A/MKLP2, CENPU, NEDD1, NINL, NPM1, NUDC, PKMYT1/MYT1, KIZ, PPP1R12A/MYPT1, PRC1, RACGAP1/CYK4, SGO1, STAG2/SA2, TEX14, TOPORS, p73/TP73, TPT1 and WEE1. Plays a key role in centrosome functions and the assembly of bipolar spindles by phosphorylating KIZ, NEDD1 and NINL. NEDD1 phosphorylation promotes subsequent targeting of the gamma-tubulin ring complex (gTuRC) to the centrosome, an important step for spindle formation. Phosphorylation of NINL component of the centrosome leads to NINL dissociation from other centrosomal proteins. Involved in mitosis exit and cytokinesis by phosphorylating CEP55, ECT2, KIF20A/MKLP2, CENPU, PRC1 and RACGAP1. Recruited at the central spindle by phosphorylating and docking PRC1 and KIF20A/MKLP2; creates its own docking sites on PRC1 and KIF20A/MKLP2 by mediating phosphorylation of sites subsequently recognized by the POLO box domains. Phosphorylates RACGAP1, thereby creating a docking site for the Rho GTP exchange factor ECT2 that is essential for the cleavage furrow formation. Promotes the central spindle recruitment of ECT2. Plays a central role in G2/M transition of mitotic cell cycle by phosphorylating CCNB1, CDC25C, FOXM1, CENPU, PKMYT1/MYT1, PPP1R12A/MYPT1 and WEE1. Part of a regulatory circuit that promotes the activation of CDK1 by phosphorylating the positive regulator CDC25C and inhibiting the negative regulators WEE1 and PKMYT1/MYT1. Also acts by mediating phosphorylation of cyclin-B1 (CCNB1) on centrosomes in prophase. Phosphorylates FOXM1, a key mitotic transcription regulator, leading to enhance FOXM1 transcriptional activity. Involved in kinetochore functions and sister chromatid cohesion by phosphorylating BUB1B/BUBR1, FBXO5/EMI1 and STAG2/SA2. PLK1 is high on non-attached kinetochores suggesting a role of PLK1 in kinetochore attachment or in spindle assembly checkpoint (SAC) regulation. Required for kinetochore localization of BUB1B. Regulates the dissociation of cohesin from chromosomes by phosphorylating cohesin subunits such as STAG2/SA2. Phosphorylates SGO1: required for spindle pole localization of isoform 3 of SGO1 and plays a role in regulating its centriole cohesion function. Mediates phosphorylation of FBXO5/EMI1, a negative regulator of the APC/C complex during prophase, leading to FBXO5/EMI1 ubiquitination and degradation by the proteasome. Acts as a negative regulator of p53 family members: phosphorylates TOPORS, leading to inhibit the sumoylation of p53/TP53 and simultaneously enhance the ubiquitination and subsequent degradation of p53/TP53. Phosphorylates the transactivation domain of the transcription factor p73/TP73, leading to inhibit p73/TP73-mediated transcriptional activation and pro-apoptotic functions. Phosphorylates BORA, and thereby promotes the degradation of BORA. Contributes to the regulation of AURKA function. Also required for recovery after DNA damage checkpoint and entry into mitosis. Phosphorylates MISP, leading to stabilization of cortical and astral microtubule attachments required for proper spindle positioning (PubMed:8991084, PubMed:11202906, PubMed:12207013, PubMed:12447691, PubMed:12524548, PubMed:12738781, PubMed:12852856, PubMed:12939256, PubMed:14532005, PubMed:14734534, PubMed:15070733, PubMed:15148369, PubMed:15469984, PubMed:16198290, PubMed:16247472, PubMed:16980960, PubMed:17081991, PubMed:17351640, PubMed:17376779, PubMed:17617734, PubMed:18174154, PubMed:18331714, PubMed:18418051, PubMed:18477460, PubMed:18521620, PubMed:18615013, PubMed:19160488, PubMed:19351716, PubMed:19468300, PubMed:19468302, PubMed:19473992, PubMed:19509060, PubMed:19597481, PubMed:23455478, PubMed:23509069). Together with MEIKIN, acts as a regulator of kinetochore function during meiosis I: required both for mono-orientation of kinetochores on sister chromosomes and protection of centromeric cohesin from separase-mediated cleavage (By similarity). Phosphorylates CEP68 and is required for its degradation (PubMed:25503564). Regulates nuclear envelope breakdown during prophase by phosphorylating DCTN1 resulting in its localization in the nuclear envelope (PubMed:20679239). Phosphorylates the heat shock transcription factor HSF1, promoting HSF1 nuclear translocation upon heat shock (PubMed:15661742). Phosphorylates HSF1 also in the early mitotic period; this phosphorylation regulates HSF1 localization to the spindle pole, the recruitment of the SCF(BTRC) ubiquitin ligase complex induicing HSF1 degradation, and hence mitotic progression (PubMed:18794143).</text>
</comment>
<comment type="catalytic activity">
<text>ATP + a protein = ADP + a phosphoprotein.</text>
</comment>
<comment type="enzyme regulation">
<text evidence="43 59">Activated by phosphorylation of Thr-210 by AURKA; phosphorylation by AURKA is enhanced by BORA. Once activated, activity is stimulated by binding target proteins. Binding of target proteins has no effect on the non-activated kinase. Several inhibitors targeting PLKs are currently in development and are under investigation in a growing number of clinical trials, such as BI 2536, an ATP-competitive PLK1 inhibitor or BI 6727, a dihydropteridinone that specifically inhibits the catalytic activity of PLK1.</text>
</comment>
<comment type="subunit">
<text evidence="27 28 29 34 35 37 38 39 42 43 44 49 51 53 54 55 58 60 61 62 64 65 67 69 70 71 72 73 74 77 78">Interacts with CEP170 and EVI5. Interacts and phosphorylates ERCC6L. Interacts with FAM29A. Interacts with SLX4/BTBD12 and TTDN1. Interacts with BUB1B. Interacts (via POLO-box domain) with the phosphorylated form of BUB1, CENPU and CDC25C. Interacts with isoform 3 of SGO1. Interacts with BORA, KIF2A and AURKA. Interacts with TOPORS and CYLD. Interacts with ECT2; the interaction is stimulated upon phosphorylation of ECT2 on 'Thr-444'. Interacts with PRC1. Interacts with KIF20A/MKLP2 (when phosphorylated), leading to the recruitment at the central spindle. Interacts (via POLO box domains) with PPP1R12A/MYPT1 (when previously phosphorylated by CDK1). Part of an astrin (SPAG5)-kinastrin (SKAP) complex containing KNSTRN, SPAG5, PLK1, DYNLL1 and SGO2. Interacts with BIRC6/bruce. Interacts with CDK1-phosphorylated FRY; this interaction occurs in mitotic cells, but not in interphase cells. FRY interaction facilitates AURKA-mediated PLK1 phosphorylation. Interacts with CDK1-phosphorylated DCTN6 during mitotic prometaphase; the interaction facilitates recruitment to kinetochores. Interacts with CEP68; the interaction phosphorylates CEP68 (PubMed:25503564). Interacts (via POLO-box domain) with DCTN1 (PubMed:20679239). Interacts with FOPNL in later G1, S, G2 and M phases of the cell cycle; this interaction recruits PLK1 to centrosomes, a step required for S phase progression (PubMed:24018379). Interacts with HSF1; this interaction increases upon heat shock but does not modulate neither HSF1 homotrimerization nor DNA-binding activities (PubMed:15661742, PubMed:18794143).</text>
</comment>
<comment type="interaction">
<interactant intactId="EBI-476768"/>
<interactant intactId="EBI-6927873">
<id>Q99IB8</id>
</interactant>
<organismsDiffer>true</organismsDiffer>
<experiments>4</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-476768"/>
<interactant intactId="EBI-1765160">
<id>Q9NR09</id>
<label>BIRC6</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>4</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-476768"/>
<interactant intactId="EBI-1180783">
<id>O96017</id>
<label>CHEK2</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>6</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-476768"/>
<interactant intactId="EBI-641940">
<id>Q60838</id>
<label>Dvl2</label>
</interactant>
<organismsDiffer>true</organismsDiffer>
<experiments>12</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-476768"/>
<interactant intactId="EBI-970310">
<id>P23588</id>
<label>EIF4B</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-476768"/>
<interactant intactId="EBI-1042535">
<id>Q2NKX8</id>
<label>ERCC6L</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-476768"/>
<interactant intactId="EBI-852291">
<id>O60447</id>
<label>EVI5</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-476768"/>
<interactant intactId="EBI-494804">
<id>Q13158</id>
<label>FADD</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>9</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-476768"/>
<interactant intactId="EBI-2511327">
<id>Q9NYZ3</id>
<label>GTSE1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>6</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-476768"/>
<interactant intactId="EBI-629985">
<id>P08107</id>
<label>HSPA1B</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>5</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-476768"/>
<interactant intactId="EBI-374819">
<id>P49736</id>
<label>MCM2</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-476768"/>
<interactant intactId="EBI-355924">
<id>P33993</id>
<label>MCM7</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>4</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-476768"/>
<interactant intactId="EBI-389668">
<id>Q00987</id>
<label>MDM2</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>7</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-476768"/>
<interactant intactId="EBI-641788">
<id>P23804</id>
<label>Mdm2</label>
</interactant>
<organismsDiffer>true</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-476768"/>
<interactant intactId="EBI-1044009">
<id>Q8TD19</id>
<label>NEK9</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>5</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-476768"/>
<interactant intactId="EBI-716327">
<id>O75665</id>
<label>OFD1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>4</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-476768"/>
<interactant intactId="EBI-713786">
<id>Q8IXK0</id>
<label>PHC2</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-476768"/>
<interactant intactId="EBI-2370740">
<id>Q8IY92</id>
<label>SLX4</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>7</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-476768"/>
<interactant intactId="EBI-356349">
<id>Q92844</id>
<label>TANK</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-476768"/>
<interactant intactId="EBI-366083">
<id>P04637</id>
<label>TP53</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>6</experiments>
</comment>
<comment type="subcellular location">
<subcellularLocation>
<location>Nucleus</location>
</subcellularLocation>
<subcellularLocation>
<location>Chromosome</location>
<location>Centromere</location>
<location>Kinetochore</location>
</subcellularLocation>
<subcellularLocation>
<location evidence="77">Cytoplasm</location>
<location evidence="77">Cytoskeleton</location>
<location evidence="77">Microtubule organizing center</location>
<location evidence="77">Centrosome</location>
</subcellularLocation>
<subcellularLocation>
<location evidence="61">Cytoplasm</location>
<location evidence="61">Cytoskeleton</location>
<location evidence="61">Spindle</location>
</subcellularLocation>
<subcellularLocation>
<location>Midbody</location>
</subcellularLocation>
<text evidence="61 77">localization at the centrosome starts at the G1/S transition (PubMed:24018379). During early stages of mitosis, the phosphorylated form is detected on centrosomes and kinetochores. Localizes to the outer kinetochore. Presence of SGO1 and interaction with the phosphorylated form of BUB1 is required for the kinetochore localization. Localizes onto the central spindle by phosphorylating and docking at midzone proteins KIF20A/MKLP2 and PRC1. Colocalizes with FRY to separating centrosomes and spindle poles from prophase to metaphase in mitosis, but not in other stages of the cell cycle. Localization to the centrosome is required for S phase progression (PubMed:24018379). Colocalizes with HSF1 at the spindle poles during prometaphase (PubMed:18794143).</text>
</comment>
<comment type="tissue specificity">
<text>Placenta and colon.</text>
</comment>
<comment type="developmental stage">
<text>Accumulates to a maximum during the G2 and M phases, declines to a nearly undetectable level following mitosis and throughout G1 phase, and then begins to accumulate again during S phase.</text>
</comment>
<comment type="induction">
<text>By growth-stimulating agents.</text>
</comment>
<comment type="domain">
<text evidence="27 28 30 46">The POLO box domains act as phosphopeptide-binding module that recognize and bind serine-[phosphothreonine/phosphoserine]-(proline/X) motifs. PLK1 recognizes and binds docking proteins that are already phosphorylated on these motifs, and then phosphorylates them. PLK1 can also create its own docking sites by mediating phosphorylation of serine-[phosphothreonine/phosphoserine]-(proline/X) motifs subsequently recognized by the POLO box domains.</text>
</comment>
<comment type="PTM">
<text evidence="20 21 24 57 59">Catalytic activity is enhanced by phosphorylation of Thr-210. Phosphorylation at Thr-210 is first detected on centrosomes in the G2 phase of the cell cycle, peaks in prometaphase and gradually disappears from centrosomes during anaphase. Dephosphorylation at Thr-210 at centrosomes is probably mediated by protein phosphatase 1C (PP1C), via interaction with PPP1R12A/MYPT1. Autophosphorylation and phosphorylation of Ser-137 may not be significant for the activation of PLK1 during mitosis, but may enhance catalytic activity during recovery after DNA damage checkpoint. Phosphorylated in vitro by STK10.</text>
</comment>
<comment type="PTM">
<text evidence="60 75">Ubiquitinated by the anaphase promoting complex/cyclosome (APC/C) in anaphase and following DNA damage, leading to its degradation by the proteasome. Ubiquitination is mediated via its interaction with FZR1/CDH1. Ubiquitination and subsequent degradation prevents entry into mitosis and is essential to maintain an efficient G2 DNA damage checkpoint. Monoubiquitination at Lys-492 by the BCR(KLHL22) ubiquitin ligase complex does not lead to degradation: it promotes PLK1 dissociation from phosphoreceptor proteins and subsequent removal from kinetochores, allowing silencing of the spindle assembly checkpoint (SAC) and chromosome segregation.</text>
</comment>
<comment type="disease">
<text>Defects in PLK1 are associated with some cancers, such as gastric, thyroid or B-cell lymphomas. Expression is cancer increased in tumor tissues with a poor prognosis, suggesting a role in malignant transformations and carcinogenesis.</text>
</comment>
<comment type="similarity">
<text evidence="18">Belongs to the protein kinase superfamily. Ser/Thr protein kinase family. CDC5/Polo subfamily.</text>
</comment>
<comment type="online information" name="Atlas of Genetics and Cytogenetics in Oncology and Haematology">
<link uri="http://atlasgeneticsoncology.org/Genes/PLK1ID41747ch16p12.html"/>
</comment>
<dbReference type="EC" id="2.7.11.21"/>
<dbReference type="EMBL" id="U01038">
<property type="protein sequence ID" value="AAA56634.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="L19559">
<property type="protein sequence ID" value="AAA36659.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="X73458">
<property type="protein sequence ID" value="CAA51837.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="X75932">
<property type="protein sequence ID" value="CAA53536.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="BC002369">
<property type="protein sequence ID" value="AAH02369.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="BC003002">
<property type="protein sequence ID" value="AAH03002.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="BC014846">
<property type="protein sequence ID" value="AAH14846.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="X90725">
<property type="protein sequence ID" value="CAA62260.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="U78073">
<property type="protein sequence ID" value="AAB36946.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="CCDS" id="CCDS10616.1"/>
<dbReference type="PIR" id="S34130">
<property type="entry name" value="S34130"/>
</dbReference>
<dbReference type="RefSeq" id="NP_005021.2">
<property type="nucleotide sequence ID" value="NM_005030.5"/>
</dbReference>
<dbReference type="UniGene" id="Hs.592049"/>
<dbReference type="PDB" id="1Q4K">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.30"/>
<property type="chains" value="A/B/C=345-603"/>
</dbReference>
<dbReference type="PDB" id="1Q4O">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.20"/>
<property type="chains" value="A/B=367-603"/>
</dbReference>
<dbReference type="PDB" id="1UMW">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.90"/>
<property type="chains" value="A/B=367-603"/>
</dbReference>
<dbReference type="PDB" id="2OGQ">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.95"/>
<property type="chains" value="A=365-603"/>
</dbReference>
<dbReference type="PDB" id="2OJX">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.85"/>
<property type="chains" value="A=365-603"/>
</dbReference>
<dbReference type="PDB" id="2OU7">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.40"/>
<property type="chains" value="A=13-345"/>
</dbReference>
<dbReference type="PDB" id="2OWB">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.10"/>
<property type="chains" value="A=13-345"/>
</dbReference>
<dbReference type="PDB" id="2RKU">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.95"/>
<property type="chains" value="A=37-330"/>
</dbReference>
<dbReference type="PDB" id="2V5Q">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.30"/>
<property type="chains" value="A/B=33-345"/>
</dbReference>
<dbReference type="PDB" id="2YAC">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.20"/>
<property type="chains" value="A=36-345"/>
</dbReference>
<dbReference type="PDB" id="3BZI">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.10"/>
<property type="chains" value="A=365-603"/>
</dbReference>
<dbReference type="PDB" id="3C5L">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.33"/>
<property type="chains" value="A=373-593"/>
</dbReference>
<dbReference type="PDB" id="3FC2">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.45"/>
<property type="chains" value="A=13-345"/>
</dbReference>
<dbReference type="PDB" id="3FVH">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.58"/>
<property type="chains" value="A=371-603"/>
</dbReference>
<dbReference type="PDB" id="3HIH">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.70"/>
<property type="chains" value="A/B=371-593"/>
</dbReference>
<dbReference type="PDB" id="3HIK">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.77"/>
<property type="chains" value="A=367-603"/>
</dbReference>
<dbReference type="PDB" id="3KB7">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.50"/>
<property type="chains" value="A=36-345"/>
</dbReference>
<dbReference type="PDB" id="3P2W">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.66"/>
<property type="chains" value="A=371-594"/>
</dbReference>
<dbReference type="PDB" id="3P2Z">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.79"/>
<property type="chains" value="A=371-594"/>
</dbReference>
<dbReference type="PDB" id="3P34">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.40"/>
<property type="chains" value="A=371-594"/>
</dbReference>
<dbReference type="PDB" id="3P35">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.09"/>
<property type="chains" value="A/B/C=371-594"/>
</dbReference>
<dbReference type="PDB" id="3P36">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.59"/>
<property type="chains" value="A=371-594"/>
</dbReference>
<dbReference type="PDB" id="3P37">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.38"/>
<property type="chains" value="A/B/C=371-594"/>
</dbReference>
<dbReference type="PDB" id="3Q1I">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.40"/>
<property type="chains" value="A=371-594"/>
</dbReference>
<dbReference type="PDB" id="3RQ7">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.55"/>
<property type="chains" value="A=371-603"/>
</dbReference>
<dbReference type="PDB" id="3THB">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.50"/>
<property type="chains" value="A=13-345"/>
</dbReference>
<dbReference type="PDB" id="4A4L">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.35"/>
<property type="chains" value="A=36-345"/>
</dbReference>
<dbReference type="PDB" id="4A4O">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.70"/>
<property type="chains" value="A=36-345"/>
</dbReference>
<dbReference type="PDB" id="4DFW">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.55"/>
<property type="chains" value="A=367-603"/>
</dbReference>
<dbReference type="PDB" id="4E67">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.10"/>
<property type="chains" value="A=371-594"/>
</dbReference>
<dbReference type="PDB" id="4E9C">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.70"/>
<property type="chains" value="A=371-594"/>
</dbReference>
<dbReference type="PDB" id="4E9D">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.75"/>
<property type="chains" value="A=371-594"/>
</dbReference>
<dbReference type="PDB" id="4H5X">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.95"/>
<property type="chains" value="A/B=367-603"/>
</dbReference>
<dbReference type="PDB" id="4H71">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.93"/>
<property type="chains" value="A/B=367-603"/>
</dbReference>
<dbReference type="PDB" id="4HAB">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.65"/>
<property type="chains" value="A/B/C=371-593"/>
</dbReference>
<dbReference type="PDB" id="4HCO">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.75"/>
<property type="chains" value="A/B=367-603"/>
</dbReference>
<dbReference type="PDB" id="4HY2">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.00"/>
<property type="chains" value="A=371-595"/>
</dbReference>
<dbReference type="PDB" id="4J52">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.30"/>
<property type="chains" value="A=38-330"/>
</dbReference>
<dbReference type="PDB" id="4J53">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.50"/>
<property type="chains" value="A=38-330"/>
</dbReference>
<dbReference type="PDB" id="4LKL">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.58"/>
<property type="chains" value="A=372-593"/>
</dbReference>
<dbReference type="PDB" id="4LKM">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.00"/>
<property type="chains" value="A/C=371-601"/>
</dbReference>
<dbReference type="PDB" id="4O56">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.80"/>
<property type="chains" value="A=367-603"/>
</dbReference>
<dbReference type="PDB" id="4O6W">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.45"/>
<property type="chains" value="A=371-603"/>
</dbReference>
<dbReference type="PDB" id="4O9W">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.69"/>
<property type="chains" value="A=373-594"/>
</dbReference>
<dbReference type="PDB" id="4RCP">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.60"/>
<property type="chains" value="A=372-599"/>
</dbReference>
<dbReference type="PDB" id="4WHH">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.90"/>
<property type="chains" value="A=371-603"/>
</dbReference>
<dbReference type="PDB" id="4WHK">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.80"/>
<property type="chains" value="A=371-603"/>
</dbReference>
<dbReference type="PDB" id="4WHL">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.71"/>
<property type="chains" value="A=371-603"/>
</dbReference>
<dbReference type="PDB" id="4X9R">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.40"/>
<property type="chains" value="A=371-603"/>
</dbReference>
<dbReference type="PDB" id="4X9V">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.43"/>
<property type="chains" value="A=371-603"/>
</dbReference>
<dbReference type="PDB" id="4X9W">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.80"/>
<property type="chains" value="A=371-603"/>
</dbReference>
<dbReference type="PDB" id="5J19">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.00"/>
<property type="chains" value="A/B=367-594"/>
</dbReference>
<dbReference type="PDB" id="5TA6">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.50"/>
<property type="chains" value="A=13-345"/>
</dbReference>
<dbReference type="PDB" id="5TA8">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.60"/>
<property type="chains" value="A=13-345"/>
</dbReference>
<dbReference type="PDBsum" id="1Q4K"/>
<dbReference type="PDBsum" id="1Q4O"/>
<dbReference type="PDBsum" id="1UMW"/>
<dbReference type="PDBsum" id="2OGQ"/>
<dbReference type="PDBsum" id="2OJX"/>
<dbReference type="PDBsum" id="2OU7"/>
<dbReference type="PDBsum" id="2OWB"/>
<dbReference type="PDBsum" id="2RKU"/>
<dbReference type="PDBsum" id="2V5Q"/>
<dbReference type="PDBsum" id="2YAC"/>
<dbReference type="PDBsum" id="3BZI"/>
<dbReference type="PDBsum" id="3C5L"/>
<dbReference type="PDBsum" id="3FC2"/>
<dbReference type="PDBsum" id="3FVH"/>
<dbReference type="PDBsum" id="3HIH"/>
<dbReference type="PDBsum" id="3HIK"/>
<dbReference type="PDBsum" id="3KB7"/>
<dbReference type="PDBsum" id="3P2W"/>
<dbReference type="PDBsum" id="3P2Z"/>
<dbReference type="PDBsum" id="3P34"/>
<dbReference type="PDBsum" id="3P35"/>
<dbReference type="PDBsum" id="3P36"/>
<dbReference type="PDBsum" id="3P37"/>
<dbReference type="PDBsum" id="3Q1I"/>
<dbReference type="PDBsum" id="3RQ7"/>
<dbReference type="PDBsum" id="3THB"/>
<dbReference type="PDBsum" id="4A4L"/>
<dbReference type="PDBsum" id="4A4O"/>
<dbReference type="PDBsum" id="4DFW"/>
<dbReference type="PDBsum" id="4E67"/>
<dbReference type="PDBsum" id="4E9C"/>
<dbReference type="PDBsum" id="4E9D"/>
<dbReference type="PDBsum" id="4H5X"/>
<dbReference type="PDBsum" id="4H71"/>
<dbReference type="PDBsum" id="4HAB"/>
<dbReference type="PDBsum" id="4HCO"/>
<dbReference type="PDBsum" id="4HY2"/>
<dbReference type="PDBsum" id="4J52"/>
<dbReference type="PDBsum" id="4J53"/>
<dbReference type="PDBsum" id="4LKL"/>
<dbReference type="PDBsum" id="4LKM"/>
<dbReference type="PDBsum" id="4O56"/>
<dbReference type="PDBsum" id="4O6W"/>
<dbReference type="PDBsum" id="4O9W"/>
<dbReference type="PDBsum" id="4RCP"/>
<dbReference type="PDBsum" id="4WHH"/>
<dbReference type="PDBsum" id="4WHK"/>
<dbReference type="PDBsum" id="4WHL"/>
<dbReference type="PDBsum" id="4X9R"/>
<dbReference type="PDBsum" id="4X9V"/>
<dbReference type="PDBsum" id="4X9W"/>
<dbReference type="PDBsum" id="5J19"/>
<dbReference type="PDBsum" id="5TA6"/>
<dbReference type="PDBsum" id="5TA8"/>
<dbReference type="DisProt" id="DP00428"/>
<dbReference type="ProteinModelPortal" id="P53350"/>
<dbReference type="SMR" id="P53350"/>
<dbReference type="BioGrid" id="111362">
<property type="interactions" value="232"/>
</dbReference>
<dbReference type="DIP" id="DIP-29696N"/>
<dbReference type="IntAct" id="P53350">
<property type="interactions" value="165"/>
</dbReference>
<dbReference type="MINT" id="MINT-86316"/>
<dbReference type="STRING" id="9606.ENSP00000300093"/>
<dbReference type="BindingDB" id="P53350"/>
<dbReference type="ChEMBL" id="CHEMBL3024"/>
<dbReference type="GuidetoPHARMACOLOGY" id="2168"/>
<dbReference type="iPTMnet" id="P53350"/>
<dbReference type="PhosphoSitePlus" id="P53350"/>
<dbReference type="BioMuta" id="PLK1"/>
<dbReference type="DMDM" id="1709658"/>
<dbReference type="EPD" id="P53350"/>
<dbReference type="MaxQB" id="P53350"/>
<dbReference type="PaxDb" id="P53350"/>
<dbReference type="PeptideAtlas" id="P53350"/>
<dbReference type="PRIDE" id="P53350"/>
<dbReference type="DNASU" id="5347"/>
<dbReference type="Ensembl" id="ENST00000300093">
<property type="protein sequence ID" value="ENSP00000300093"/>
<property type="gene ID" value="ENSG00000166851"/>
</dbReference>
<dbReference type="GeneID" id="5347"/>
<dbReference type="KEGG" id="hsa:5347"/>
<dbReference type="UCSC" id="uc002dlz.2">
<property type="organism name" value="human"/>
</dbReference>
<dbReference type="CTD" id="5347"/>
<dbReference type="DisGeNET" id="5347"/>
<dbReference type="GeneCards" id="PLK1"/>
<dbReference type="HGNC" id="HGNC:9077">
<property type="gene designation" value="PLK1"/>
</dbReference>
<dbReference type="HPA" id="HPA051638"/>
<dbReference type="HPA" id="HPA053229"/>
<dbReference type="MIM" id="602098">
<property type="type" value="gene"/>
</dbReference>
<dbReference type="neXtProt" id="NX_P53350"/>
<dbReference type="OpenTargets" id="ENSG00000166851"/>
<dbReference type="PharmGKB" id="PA33410"/>
<dbReference type="eggNOG" id="KOG0575">
<property type="taxonomic scope" value="Eukaryota"/>
</dbReference>
<dbReference type="eggNOG" id="ENOG410XQBP">
<property type="taxonomic scope" value="LUCA"/>
</dbReference>
<dbReference type="GeneTree" id="ENSGT00530000062954"/>
<dbReference type="HOGENOM" id="HOG000248546"/>
<dbReference type="HOVERGEN" id="HBG001843"/>
<dbReference type="InParanoid" id="P53350"/>
<dbReference type="KO" id="K06631"/>
<dbReference type="OMA" id="KRYMTEH"/>
<dbReference type="OrthoDB" id="EOG091G0D89"/>
<dbReference type="PhylomeDB" id="P53350"/>
<dbReference type="TreeFam" id="TF101089"/>
<dbReference type="BRENDA" id="2.7.11.21">
<property type="organism ID" value="2681"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-156711">
<property type="pathway name" value="Polo-like kinase mediated events"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-162658">
<property type="pathway name" value="Golgi Cisternae Pericentriolar Stack Reorganization"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-174178">
<property type="pathway name" value="APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-176412">
<property type="pathway name" value="Phosphorylation of the APC/C"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-176417">
<property type="pathway name" value="Phosphorylation of Emi1"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-2299718">
<property type="pathway name" value="Condensation of Prophase Chromosomes"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-2467813">
<property type="pathway name" value="Separation of Sister Chromatids"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-2500257">
<property type="pathway name" value="Resolution of Sister Chromatid Cohesion"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-2565942">
<property type="pathway name" value="Regulation of PLK1 Activity at G2/M Transition"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-2980767">
<property type="pathway name" value="Activation of NIMA Kinases NEK9, NEK6, NEK7"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-380259">
<property type="pathway name" value="Loss of Nlp from mitotic centrosomes"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-380270">
<property type="pathway name" value="Recruitment of mitotic centrosome proteins and complexes"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-380284">
<property type="pathway name" value="Loss of proteins required for interphase microtubule organization from the centrosome"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-5620912">
<property type="pathway name" value="Anchoring of the basal body to the plasma membrane"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-5663220">
<property type="pathway name" value="RHO GTPases Activate Formins"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-68877">
<property type="pathway name" value="Mitotic Prometaphase"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-68881">
<property type="pathway name" value="Mitotic Metaphase/Anaphase Transition"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-68884">
<property type="pathway name" value="Mitotic Telophase/Cytokinesis"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-69273">
<property type="pathway name" value="Cyclin A/B1 associated events during G2/M transition"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-8852276">
<property type="pathway name" value="The role of GTSE1 in G2/M progression after G2 checkpoint"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-8854518">
<property type="pathway name" value="AURKA Activation by TPX2"/>
</dbReference>
<dbReference type="SignaLink" id="P53350"/>
<dbReference type="SIGNOR" id="P53350"/>
<dbReference type="ChiTaRS" id="PLK1">
<property type="organism name" value="human"/>
</dbReference>
<dbReference type="EvolutionaryTrace" id="P53350"/>
<dbReference type="GeneWiki" id="PLK1"/>
<dbReference type="GenomeRNAi" id="5347"/>
<dbReference type="PRO" id="PR:P53350"/>
<dbReference type="Proteomes" id="UP000005640">
<property type="component" value="Chromosome 16"/>
</dbReference>
<dbReference type="Bgee" id="ENSG00000166851"/>
<dbReference type="CleanEx" id="HS_PLK1"/>
<dbReference type="ExpressionAtlas" id="P53350">
<property type="expression patterns" value="baseline and differential"/>
</dbReference>
<dbReference type="Genevisible" id="P53350">
<property type="organism ID" value="HS"/>
</dbReference>
<dbReference type="GO" id="GO:0005813">
<property type="term" value="C:centrosome"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0000785">
<property type="term" value="C:chromatin"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0000942">
<property type="term" value="C:condensed nuclear chromosome outer kinetochore"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0005829">
<property type="term" value="C:cytosol"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0000776">
<property type="term" value="C:kinetochore"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0015630">
<property type="term" value="C:microtubule cytoskeleton"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0030496">
<property type="term" value="C:midbody"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0005654">
<property type="term" value="C:nucleoplasm"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0005634">
<property type="term" value="C:nucleus"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0005819">
<property type="term" value="C:spindle"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0051233">
<property type="term" value="C:spindle midzone"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0000922">
<property type="term" value="C:spindle pole"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0000795">
<property type="term" value="C:synaptonemal complex"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0010997">
<property type="term" value="F:anaphase-promoting complex binding"/>
<property type="evidence" value="ECO:0000353"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0005524">
<property type="term" value="F:ATP binding"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="CAFA"/>
</dbReference>
<dbReference type="GO" id="GO:0016301">
<property type="term" value="F:kinase activity"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0000287">
<property type="term" value="F:magnesium ion binding"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="CAFA"/>
</dbReference>
<dbReference type="GO" id="GO:0008017">
<property type="term" value="F:microtubule binding"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0004672">
<property type="term" value="F:protein kinase activity"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0019901">
<property type="term" value="F:protein kinase binding"/>
<property type="evidence" value="ECO:0000353"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0004674">
<property type="term" value="F:protein serine/threonine kinase activity"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0031145">
<property type="term" value="P:anaphase-promoting complex-dependent catabolic process"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0008283">
<property type="term" value="P:cell proliferation"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="ProtInc"/>
</dbReference>
<dbReference type="GO" id="GO:0051297">
<property type="term" value="P:centrosome organization"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0097711">
<property type="term" value="P:ciliary basal body docking"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0000910">
<property type="term" value="P:cytokinesis"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0045184">
<property type="term" value="P:establishment of protein localization"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="MGI"/>
</dbReference>
<dbReference type="GO" id="GO:0016321">
<property type="term" value="P:female meiosis chromosome segregation"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0031572">
<property type="term" value="P:G2 DNA damage checkpoint"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0000086">
<property type="term" value="P:G2/M transition of mitotic cell cycle"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0045143">
<property type="term" value="P:homologous chromosome segregation"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0001578">
<property type="term" value="P:microtubule bundle formation"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0000281">
<property type="term" value="P:mitotic cytokinesis"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0007067">
<property type="term" value="P:mitotic nuclear division"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0007077">
<property type="term" value="P:mitotic nuclear envelope disassembly"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0000070">
<property type="term" value="P:mitotic sister chromatid segregation"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0007094">
<property type="term" value="P:mitotic spindle assembly checkpoint"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0043066">
<property type="term" value="P:negative regulation of apoptotic process"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0045736">
<property type="term" value="P:negative regulation of cyclin-dependent protein serine/threonine kinase activity"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0000122">
<property type="term" value="P:negative regulation of transcription from RNA polymerase II promoter"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0051081">
<property type="term" value="P:nuclear envelope disassembly"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0018105">
<property type="term" value="P:peptidyl-serine phosphorylation"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0010800">
<property type="term" value="P:positive regulation of peptidyl-threonine phosphorylation"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0032436">
<property type="term" value="P:positive regulation of proteasomal ubiquitin-dependent protein catabolic process"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:1900182">
<property type="term" value="P:positive regulation of protein localization to nucleus"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0045862">
<property type="term" value="P:positive regulation of proteolysis"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:1904668">
<property type="term" value="P:positive regulation of ubiquitin protein ligase activity"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0051437">
<property type="term" value="P:positive regulation of ubiquitin-protein ligase activity involved in regulation of mitotic cell cycle transition"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0051443">
<property type="term" value="P:positive regulation of ubiquitin-protein transferase activity"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0031648">
<property type="term" value="P:protein destabilization"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0071168">
<property type="term" value="P:protein localization to chromatin"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0090435">
<property type="term" value="P:protein localization to nuclear envelope"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0006468">
<property type="term" value="P:protein phosphorylation"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0016567">
<property type="term" value="P:protein ubiquitination"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0042787">
<property type="term" value="P:protein ubiquitination involved in ubiquitin-dependent protein catabolic process"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0051726">
<property type="term" value="P:regulation of cell cycle"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:1902749">
<property type="term" value="P:regulation of cell cycle G2/M phase transition"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0007346">
<property type="term" value="P:regulation of mitotic cell cycle"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0030071">
<property type="term" value="P:regulation of mitotic metaphase/anaphase transition"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:1901673">
<property type="term" value="P:regulation of mitotic spindle assembly"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="CACAO"/>
</dbReference>
<dbReference type="GO" id="GO:0043393">
<property type="term" value="P:regulation of protein binding"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0051439">
<property type="term" value="P:regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0007062">
<property type="term" value="P:sister chromatid cohesion"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0070194">
<property type="term" value="P:synaptonemal complex disassembly"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="CDD" id="cd13118">
<property type="entry name" value="POLO_box_1"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="CDD" id="cd13117">
<property type="entry name" value="POLO_box_2"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="CDD" id="cd14187">
<property type="entry name" value="STKc_PLK1"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="Gene3D" id="3.30.1120.30">
<property type="match status" value="2"/>
</dbReference>
<dbReference type="InterPro" id="IPR011009">
<property type="entry name" value="Kinase-like_dom"/>
</dbReference>
<dbReference type="InterPro" id="IPR033702">
<property type="entry name" value="PLK1_cat"/>
</dbReference>
<dbReference type="InterPro" id="IPR033701">
<property type="entry name" value="POLO_box_1"/>
</dbReference>
<dbReference type="InterPro" id="IPR033695">
<property type="entry name" value="POLO_box_2"/>
</dbReference>
<dbReference type="InterPro" id="IPR000959">
<property type="entry name" value="POLO_box_dom"/>
</dbReference>
<dbReference type="InterPro" id="IPR000719">
<property type="entry name" value="Prot_kinase_dom"/>
</dbReference>
<dbReference type="InterPro" id="IPR017441">
<property type="entry name" value="Protein_kinase_ATP_BS"/>
</dbReference>
<dbReference type="InterPro" id="IPR008271">
<property type="entry name" value="Ser/Thr_kinase_AS"/>
</dbReference>
<dbReference type="Pfam" id="PF00069">
<property type="entry name" value="Pkinase"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="Pfam" id="PF00659">
<property type="entry name" value="POLO_box"/>
<property type="match status" value="2"/>
</dbReference>
<dbReference type="SMART" id="SM00220">
<property type="entry name" value="S_TKc"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="SUPFAM" id="SSF56112">
<property type="entry name" value="SSF56112"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PROSITE" id="PS50078">
<property type="entry name" value="POLO_BOX"/>
<property type="match status" value="2"/>
</dbReference>
<dbReference type="PROSITE" id="PS00107">
<property type="entry name" value="PROTEIN_KINASE_ATP"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PROSITE" id="PS50011">
<property type="entry name" value="PROTEIN_KINASE_DOM"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PROSITE" id="PS00108">
<property type="entry name" value="PROTEIN_KINASE_ST"/>
<property type="match status" value="1"/>
</dbReference>
<proteinExistence type="evidence at protein level"/>
<keyword id="KW-0002">3D-structure</keyword>
<keyword id="KW-0007">Acetylation</keyword>
<keyword id="KW-0067">ATP-binding</keyword>
<keyword id="KW-0131">Cell cycle</keyword>
<keyword id="KW-0132">Cell division</keyword>
<keyword id="KW-0137">Centromere</keyword>
<keyword id="KW-0158">Chromosome</keyword>
<keyword id="KW-0181">Complete proteome</keyword>
<keyword id="KW-0963">Cytoplasm</keyword>
<keyword id="KW-0206">Cytoskeleton</keyword>
<keyword id="KW-1017">Isopeptide bond</keyword>
<keyword id="KW-0418">Kinase</keyword>
<keyword id="KW-0995">Kinetochore</keyword>
<keyword id="KW-0498">Mitosis</keyword>
<keyword id="KW-0547">Nucleotide-binding</keyword>
<keyword id="KW-0539">Nucleus</keyword>
<keyword id="KW-0597">Phosphoprotein</keyword>
<keyword id="KW-0621">Polymorphism</keyword>
<keyword id="KW-1185">Reference proteome</keyword>
<keyword id="KW-0677">Repeat</keyword>
<keyword id="KW-0723">Serine/threonine-protein kinase</keyword>
<keyword id="KW-0808">Transferase</keyword>
<keyword id="KW-0832">Ubl conjugation</keyword>
<feature type="initiator methionine" description="Removed" evidence="13">
<location>
<position position="1"/>
</location>
</feature>
<feature type="chain" description="Serine/threonine-protein kinase PLK1" id="PRO_0000086556">
<location>
<begin position="2"/>
<end position="603"/>
</location>
</feature>
<feature type="domain" description="Protein kinase" evidence="18">
<location>
<begin position="53"/>
<end position="305"/>
</location>
</feature>
<feature type="domain" description="POLO box 1" evidence="17">
<location>
<begin position="417"/>
<end position="480"/>
</location>
</feature>
<feature type="domain" description="POLO box 2" evidence="17">
<location>
<begin position="515"/>
<end position="584"/>
</location>
</feature>
<feature type="nucleotide phosphate-binding region" description="ATP">
<location>
<begin position="59"/>
<end position="67"/>
</location>
</feature>
<feature type="nucleotide phosphate-binding region" description="ATP">
<location>
<begin position="178"/>
<end position="181"/>
</location>
</feature>
<feature type="region of interest" description="Activation loop">
<location>
<begin position="194"/>
<end position="221"/>
</location>
</feature>
<feature type="region of interest" description="Linker">
<location>
<begin position="493"/>
<end position="507"/>
</location>
</feature>
<feature type="region of interest" description="Important for interaction with phosphorylated proteins" evidence="15">
<location>
<begin position="538"/>
<end position="540"/>
</location>
</feature>
<feature type="short sequence motif" description="D-box that targets the protein for proteasomal degradation in anaphase">
<location>
<begin position="337"/>
<end position="340"/>
</location>
</feature>
<feature type="active site" description="Proton acceptor">
<location>
<position position="176"/>
</location>
</feature>
<feature type="binding site" description="ATP">
<location>
<position position="82"/>
</location>
</feature>
<feature type="binding site" description="ATP; via carbonyl oxygen">
<location>
<position position="131"/>
</location>
</feature>
<feature type="binding site" description="ATP">
<location>
<position position="194"/>
</location>
</feature>
<feature type="modified residue" description="N-acetylserine" evidence="13">
<location>
<position position="2"/>
</location>
</feature>
<feature type="modified residue" description="Phosphothreonine" evidence="10">
<location>
<position position="6"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="10">
<location>
<position position="103"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="81">
<location>
<position position="137"/>
</location>
</feature>
<feature type="modified residue" description="Phosphothreonine; by AURKA" evidence="9 10 11 12 14 20 57 59">
<location>
<position position="210"/>
</location>
</feature>
<feature type="modified residue" description="Phosphothreonine" evidence="9 10 11">
<location>
<position position="214"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine; by autocatalysis" evidence="15">
<location>
<position position="269"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="21">
<location>
<position position="335"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="10">
<location>
<position position="375"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="10">
<location>
<position position="450"/>
</location>
</feature>
<feature type="modified residue" description="Phosphothreonine" evidence="10">
<location>
<position position="498"/>
</location>
</feature>
<feature type="cross-link" description="Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin)" evidence="60">
<location>
<position position="19"/>
</location>
</feature>
<feature type="cross-link" description="Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin)" evidence="75">
<location>
<position position="492"/>
</location>
</feature>
<feature type="sequence variant" description="In a lung squamous cell carcinoma sample; somatic mutation." id="VAR_041018" evidence="45">
<original>R</original>
<variation>L</variation>
<location>
<position position="12"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs35056440." id="VAR_041019" evidence="45">
<original>L</original>
<variation>F</variation>
<location>
<position position="261"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs16972799." id="VAR_051659">
<original>N</original>
<variation>D</variation>
<location>
<position position="297"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs45489499." id="VAR_041020" evidence="45">
<original>L</original>
<variation>V</variation>
<location>
<position position="332"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs45569335." id="VAR_041021" evidence="45">
<original>L</original>
<variation>H</variation>
<location>
<position position="463"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs56027600." id="VAR_041022" evidence="45">
<original>R</original>
<variation>H</variation>
<location>
<position position="518"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs34001032." id="VAR_051660">
<original>S</original>
<variation>L</variation>
<location>
<position position="595"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs34954545." id="VAR_051661">
<original>R</original>
<variation>H</variation>
<location>
<position position="599"/>
</location>
</feature>
<feature type="mutagenesis site" description="In analog-sensitive mutant; enlarged catalytic pocket to accommodate purine analogs; when associated with G-130." evidence="66">
<original>C</original>
<variation>V</variation>
<location>
<position position="67"/>
</location>
</feature>
<feature type="mutagenesis site" description="Loss of kinase activity. No effect on S-phase progression." evidence="20 22 52 77">
<original>K</original>
<variation>M</variation>
<location>
<position position="82"/>
</location>
</feature>
<feature type="mutagenesis site" description="Loss of kinase activity." evidence="59 63">
<original>K</original>
<variation>R</variation>
<location>
<position position="82"/>
</location>
</feature>
<feature type="mutagenesis site" description="In analog-sensitive mutant; enlarged catalytic pocket to accommodate purine analogs; when associated with V-67." evidence="66">
<original>L</original>
<variation>G</variation>
<location>
<position position="130"/>
</location>
</feature>
<feature type="mutagenesis site" description="No change in activity. Increases activity and restores recovery after DNA damage checkpoint; when associated with D-210." evidence="20 59">
<original>S</original>
<variation>A</variation>
<location>
<position position="137"/>
</location>
</feature>
<feature type="mutagenesis site" description="Increases activity. Results in a block in G1/S." evidence="20 59">
<original>S</original>
<variation>D</variation>
<location>
<position position="137"/>
</location>
</feature>
<feature type="mutagenesis site" description="Abolishes kinase activity." evidence="59">
<original>D</original>
<variation>N</variation>
<location>
<position position="176"/>
</location>
</feature>
<feature type="mutagenesis site" description="Does not interfere with FRY-binding." evidence="73">
<original>D</original>
<variation>A</variation>
<location>
<position position="194"/>
</location>
</feature>
<feature type="mutagenesis site" description="Abolishes activity. Abolishes checkpoint recovery." evidence="20 22 48 59 63">
<original>T</original>
<variation>A</variation>
<location>
<position position="210"/>
</location>
</feature>
<feature type="mutagenesis site" description="Increases activity and restores recovery after DNA damage checkpoint." evidence="20 22 48 59 63">
<original>T</original>
<variation>D</variation>
<location>
<position position="210"/>
</location>
</feature>
<feature type="mutagenesis site" description="Reduced catalytic activity, but no effect on affinity for ATP." evidence="20 22 48 59 63">
<original>T</original>
<variation>V</variation>
<location>
<position position="210"/>
</location>
</feature>
<feature type="mutagenesis site" description="Interferes with ubiquitination and subsequent proteasomal degradation in anaphase; when associated with A-340." evidence="30 60">
<original>R</original>
<variation>A</variation>
<location>
<position position="337"/>
</location>
</feature>
<feature type="mutagenesis site" description="Interferes with ubiquitination and subsequent proteasomal degradation in anaphase; when associated with A-337." evidence="30 60">
<original>L</original>
<variation>A</variation>
<location>
<position position="340"/>
</location>
</feature>
<feature type="mutagenesis site" description="Abolishes interaction with CDC25C and reduces centrosomal localization." evidence="43">
<original>W</original>
<variation>F</variation>
<location>
<position position="414"/>
</location>
</feature>
<feature type="mutagenesis site" description="No effect on centrosomal localization, nor on S-phase progression; when asscociated with A-427. Loss of centrosomal localization and of S-phase progression; when associated with A- 415 and A-427." evidence="77">
<original>W</original>
<variation>F</variation>
<location>
<position position="414"/>
</location>
</feature>
<feature type="mutagenesis site" description="Loss of centrosomal localization and of S-phase progression; when associated with A- 414 and A-427." evidence="77">
<original>V</original>
<variation>A</variation>
<location>
<position position="415"/>
</location>
</feature>
<feature type="mutagenesis site" description="No effect on centrosomal localization, nor on S-phase progression; when associated with A-414. Loss of centrosomal localization and of S-phase progression; when associated with A- 414 and A-415." evidence="77">
<original>L</original>
<variation>A</variation>
<location>
<position position="427"/>
</location>
</feature>
<feature type="mutagenesis site" description="Severe mitotic defects leading to prometaphase delay. Increased localization at kinetochores leading to increased levels of phosphorylated BUBR1." evidence="75">
<original>K</original>
<variation>R</variation>
<location>
<position position="492"/>
</location>
</feature>
<feature type="mutagenesis site" description="In pincer mutant; loss of centrosomal location and decreased interaction with phosphorylated CDC25C and BUB1; when associated with M-540." evidence="28 39 57 66">
<original>H</original>
<variation>A</variation>
<location>
<position position="538"/>
</location>
</feature>
<feature type="mutagenesis site" description="In pincer mutant; loss of centrosomal location and decreased interaction with phosphorylated CDC25C and BUB1; when associated with A-538." evidence="28 39 57 66">
<original>K</original>
<variation>M</variation>
<location>
<position position="540"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 1; AAA56634." ref="1" evidence="80">
<original>S</original>
<variation>T</variation>
<location>
<position position="2"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 1; AAA56634." ref="1" evidence="80">
<original>A</original>
<variation>P</variation>
<location>
<position position="11"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 1; AAA56634." ref="1" evidence="80">
<original>F</original>
<variation>L</variation>
<location>
<position position="58"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 1; AAA56634." ref="1" evidence="80">
<original>G</original>
<variation>S</variation>
<location>
<position position="60"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 2; AAA36659 and 7; AAB36946." ref="2 7" evidence="80">
<original>A</original>
<variation>V</variation>
<location>
<position position="73"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 6; CAA62260." ref="6" evidence="80">
<original>N</original>
<variation>T</variation>
<location>
<position position="123"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 4; CAA53536." ref="4" evidence="80">
<original>L</original>
<variation>P</variation>
<location>
<position position="141"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 4; CAA53536." ref="4" evidence="80">
<original>G</original>
<variation>E</variation>
<location>
<position position="227"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 2; AAA36659." ref="2" evidence="80">
<original>N</original>
<variation>G</variation>
<location>
<position position="301"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 2; AAA36659." ref="2" evidence="80">
<original>A</original>
<variation>G</variation>
<location>
<position position="495"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 2; AAA36659." ref="2" evidence="80">
<original>E</original>
<variation>Q</variation>
<location>
<position position="501"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="42"/>
<end position="46"/>
</location>
</feature>
<feature type="turn" evidence="1">
<location>
<begin position="47"/>
<end position="50"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="51"/>
<end position="62"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="65"/>
<end position="72"/>
</location>
</feature>
<feature type="turn" evidence="1">
<location>
<begin position="73"/>
<end position="75"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="78"/>
<end position="85"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="86"/>
<end position="88"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="92"/>
<end position="106"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="116"/>
<end position="121"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="123"/>
<end position="131"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="138"/>
<end position="145"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="150"/>
<end position="169"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="179"/>
<end position="181"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="182"/>
<end position="184"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="190"/>
<end position="192"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="220"/>
<end position="223"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="224"/>
<end position="226"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="231"/>
<end position="246"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="256"/>
<end position="264"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="276"/>
<end position="285"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="290"/>
<end position="292"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="296"/>
<end position="301"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="303"/>
<end position="306"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="316"/>
<end position="319"/>
</location>
</feature>
<feature type="helix" evidence="8">
<location>
<begin position="367"/>
<end position="370"/>
</location>
</feature>
<feature type="helix" evidence="7">
<location>
<begin position="374"/>
<end position="386"/>
</location>
</feature>
<feature type="helix" evidence="7">
<location>
<begin position="389"/>
<end position="391"/>
</location>
</feature>
<feature type="strand" evidence="3">
<location>
<begin position="392"/>
<end position="394"/>
</location>
</feature>
<feature type="helix" evidence="7">
<location>
<begin position="397"/>
<end position="400"/>
</location>
</feature>
<feature type="helix" evidence="7">
<location>
<begin position="403"/>
<end position="405"/>
</location>
</feature>
<feature type="strand" evidence="7">
<location>
<begin position="411"/>
<end position="417"/>
</location>
</feature>
<feature type="turn" evidence="7">
<location>
<begin position="418"/>
<end position="421"/>
</location>
</feature>
<feature type="strand" evidence="7">
<location>
<begin position="422"/>
<end position="427"/>
</location>
</feature>
<feature type="strand" evidence="7">
<location>
<begin position="432"/>
<end position="436"/>
</location>
</feature>
<feature type="strand" evidence="7">
<location>
<begin position="441"/>
<end position="444"/>
</location>
</feature>
<feature type="strand" evidence="7">
<location>
<begin position="448"/>
<end position="454"/>
</location>
</feature>
<feature type="strand" evidence="7">
<location>
<begin position="460"/>
<end position="464"/>
</location>
</feature>
<feature type="turn" evidence="4">
<location>
<begin position="465"/>
<end position="467"/>
</location>
</feature>
<feature type="helix" evidence="7">
<location>
<begin position="470"/>
<end position="472"/>
</location>
</feature>
<feature type="helix" evidence="7">
<location>
<begin position="473"/>
<end position="488"/>
</location>
</feature>
<feature type="turn" evidence="7">
<location>
<begin position="493"/>
<end position="496"/>
</location>
</feature>
<feature type="turn" evidence="3">
<location>
<begin position="503"/>
<end position="505"/>
</location>
</feature>
<feature type="strand" evidence="7">
<location>
<begin position="511"/>
<end position="516"/>
</location>
</feature>
<feature type="strand" evidence="7">
<location>
<begin position="518"/>
<end position="525"/>
</location>
</feature>
<feature type="turn" evidence="6">
<location>
<begin position="526"/>
<end position="528"/>
</location>
</feature>
<feature type="strand" evidence="7">
<location>
<begin position="530"/>
<end position="534"/>
</location>
</feature>
<feature type="turn" evidence="7">
<location>
<begin position="535"/>
<end position="537"/>
</location>
</feature>
<feature type="strand" evidence="7">
<location>
<begin position="540"/>
<end position="544"/>
</location>
</feature>
<feature type="turn" evidence="7">
<location>
<begin position="545"/>
<end position="548"/>
</location>
</feature>
<feature type="strand" evidence="7">
<location>
<begin position="549"/>
<end position="553"/>
</location>
</feature>
<feature type="strand" evidence="7">
<location>
<begin position="559"/>
<end position="563"/>
</location>
</feature>
<feature type="helix" evidence="7">
<location>
<begin position="564"/>
<end position="570"/>
</location>
</feature>
<feature type="helix" evidence="7">
<location>
<begin position="574"/>
<end position="591"/>
</location>
</feature>
<feature type="strand" evidence="5">
<location>
<begin position="593"/>
<end position="595"/>
</location>
</feature>
<feature type="strand" evidence="5">
<location>
<begin position="598"/>
<end position="602"/>
</location>
</feature>
<evidence key="1" type="ECO:0000244">
<source>
<dbReference type="PDB" id="2RKU"/>
</source>
</evidence>
<evidence key="2" type="ECO:0000244">
<source>
<dbReference type="PDB" id="2V5Q"/>
</source>
</evidence>
<evidence key="3" type="ECO:0000244">
<source>
<dbReference type="PDB" id="3P34"/>
</source>
</evidence>
<evidence key="4" type="ECO:0000244">
<source>
<dbReference type="PDB" id="3Q1I"/>
</source>
</evidence>
<evidence key="5" type="ECO:0000244">
<source>
<dbReference type="PDB" id="4O56"/>
</source>
</evidence>
<evidence key="6" type="ECO:0000244">
<source>
<dbReference type="PDB" id="4WHL"/>
</source>
</evidence>
<evidence key="7" type="ECO:0000244">
<source>
<dbReference type="PDB" id="4X9R"/>
</source>
</evidence>
<evidence key="8" type="ECO:0000244">
<source>
<dbReference type="PDB" id="5J19"/>
</source>
</evidence>
<evidence key="9" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="18669648"/>
</source>
</evidence>
<evidence key="10" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="18691976"/>
</source>
</evidence>
<evidence key="11" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="19369195"/>
</source>
</evidence>
<evidence key="12" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="20068231"/>
</source>
</evidence>
<evidence key="13" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="22814378"/>
</source>
</evidence>
<evidence key="14" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="23186163"/>
</source>
</evidence>
<evidence key="15" type="ECO:0000250"/>
<evidence key="16" type="ECO:0000250">
<source>
<dbReference type="UniProtKB" id="Q5F2C3"/>
</source>
</evidence>
<evidence key="17" type="ECO:0000255">
<source>
<dbReference type="PROSITE-ProRule" id="PRU00154"/>
</source>
</evidence>
<evidence key="18" type="ECO:0000255">
<source>
<dbReference type="PROSITE-ProRule" id="PRU00159"/>
</source>
</evidence>
<evidence key="19" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="11202906"/>
</source>
</evidence>
<evidence key="20" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="12207013"/>
</source>
</evidence>
<evidence key="21" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="12442251"/>
</source>
</evidence>
<evidence key="22" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="12447691"/>
</source>
</evidence>
<evidence key="23" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="12524548"/>
</source>
</evidence>
<evidence key="24" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="12639966"/>
</source>
</evidence>
<evidence key="25" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="12738781"/>
</source>
</evidence>
<evidence key="26" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="12852856"/>
</source>
</evidence>
<evidence key="27" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="12939256"/>
</source>
</evidence>
<evidence key="28" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="14532005"/>
</source>
</evidence>
<evidence key="29" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="14592974"/>
</source>
</evidence>
<evidence key="30" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="14734534"/>
</source>
</evidence>
<evidence key="31" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="15070733"/>
</source>
</evidence>
<evidence key="32" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="15148369"/>
</source>
</evidence>
<evidence key="33" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="15469984"/>
</source>
</evidence>
<evidence key="34" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="15616186"/>
</source>
</evidence>
<evidence key="35" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="15661742"/>
</source>
</evidence>
<evidence key="36" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="16198290"/>
</source>
</evidence>
<evidence key="37" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="16247472"/>
</source>
</evidence>
<evidence key="38" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="16439210"/>
</source>
</evidence>
<evidence key="39" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="16760428"/>
</source>
</evidence>
<evidence key="40" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="16980960"/>
</source>
</evidence>
<evidence key="41" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="17081991"/>
</source>
</evidence>
<evidence key="42" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="17218258"/>
</source>
</evidence>
<evidence key="43" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="17307877"/>
</source>
</evidence>
<evidence key="44" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="17310276"/>
</source>
</evidence>
<evidence key="45" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="17344846"/>
</source>
</evidence>
<evidence key="46" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="17351640"/>
</source>
</evidence>
<evidence key="47" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="17376779"/>
</source>
</evidence>
<evidence key="48" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="17461553"/>
</source>
</evidence>
<evidence key="49" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="17495026"/>
</source>
</evidence>
<evidence key="50" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="17617734"/>
</source>
</evidence>
<evidence key="51" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="18005335"/>
</source>
</evidence>
<evidence key="52" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="18174154"/>
</source>
</evidence>
<evidence key="53" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="18329369"/>
</source>
</evidence>
<evidence key="54" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="18331714"/>
</source>
</evidence>
<evidence key="55" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="18391401"/>
</source>
</evidence>
<evidence key="56" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="18418051"/>
</source>
</evidence>
<evidence key="57" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="18477460"/>
</source>
</evidence>
<evidence key="58" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="18521620"/>
</source>
</evidence>
<evidence key="59" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="18615013"/>
</source>
</evidence>
<evidence key="60" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="18662541"/>
</source>
</evidence>
<evidence key="61" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="18794143"/>
</source>
</evidence>
<evidence key="62" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="19029337"/>
</source>
</evidence>
<evidence key="63" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="19160488"/>
</source>
</evidence>
<evidence key="64" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="19351716"/>
</source>
</evidence>
<evidence key="65" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="19468300"/>
</source>
</evidence>
<evidence key="66" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="19468302"/>
</source>
</evidence>
<evidence key="67" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="19473992"/>
</source>
</evidence>
<evidence key="68" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="19509060"/>
</source>
</evidence>
<evidence key="69" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="19596235"/>
</source>
</evidence>
<evidence key="70" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="19597481"/>
</source>
</evidence>
<evidence key="71" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="20679239"/>
</source>
</evidence>
<evidence key="72" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="21402792"/>
</source>
</evidence>
<evidence key="73" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="22753416"/>
</source>
</evidence>
<evidence key="74" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="23455152"/>
</source>
</evidence>
<evidence key="75" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="23455478"/>
</source>
</evidence>
<evidence key="76" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="23509069"/>
</source>
</evidence>
<evidence key="77" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="24018379"/>
</source>
</evidence>
<evidence key="78" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="25503564"/>
</source>
</evidence>
<evidence key="79" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="8991084"/>
</source>
</evidence>
<evidence key="80" type="ECO:0000305"/>
<evidence key="81" type="ECO:0000305">
<source>
<dbReference type="PubMed" id="12207013"/>
</source>
</evidence>
<sequence length="603" mass="68255" checksum="178C2F13C10E8206" modified="1996-10-01" version="1">
MSAAVTAGKLARAPADPGKAGVPGVAAPGAPAAAPPAKEIPEVLVDPRSRRRYVRGRFLG
KGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFF
EDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLG
NLFLNEDLEVKIGDFGLATKVEYDGERKKTLCGTPNYIAPEVLSKKGHSFEVDVWSIGCI
MYTLLVGKPPFETSCLKETYLRIKKNEYSIPKHINPVAASLIQKMLQTDPTARPTINELL
NDEFFTSGYIPARLPITCLTIPPRFSIAPSSLDPSNRKPLTVLNKGLENPLPERPREKEE
PVVRETGEVVDCHLSDMLQQLHSVNASKPSERGLVRQEEAEDPACIPIFWVSKWVDYSDK
YGLGYQLCDNSVGVLFNDSTRLILYNDGDSLQYIERDGTESYLTVSSHPNSLMKKITLLK
YFRNYMSEHLLKAGANITPREGDELARLPYLRTWFRTRSAIILHLSNGSVQINFFQDHTK
LILCPLMAAVTYIDEKRDFRTYRLSLLEEYGCCKELASRLRYARTMVDKLLSSRSASNRL
KAS
</sequence>
</entry>
<copyright>
Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
Distributed under the Creative Commons Attribution-NoDerivs License
</copyright>
</uniprot>